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ABSTRACT 
Tissue Damage Characterization Using Non-invasive Optical Modalities 
David Diaz 
Leonid Zubkov, Ph.D. 
Peter A. Lewin, Ph.D. 
 
 
 
The ability to determine the degree of cutaneous and subcutaneous tissue damage is 
essential for proper wound assessment and a significant factor for determining patient 
treatment and morbidity. Accurate characterization of tissue damage is critical for a 
number of medical applications including surgical removal of nonviable tissue, severity 
assessment of subcutaneous ulcers, and depth assessment of visually open wounds. The 
main objective of this research was to develop a non-invasive method for identifying the 
extent of tissue damage underneath intact skin that is not apparent upon visual 
examination. This work investigated the relationship between tissue optical properties, 
blood flow, and tissue viability by testing the hypotheses that (a) changes in tissue 
oxygenation and/or microcirculatory blood flow measurable by Diffuse Near Infrared 
Spectroscopy (DNIRS) and Diffuse Correlation Spectroscopy (DCS) differ between 
healthy and damaged tissue and (b) the magnitude of those changes differs for different 
degrees of tissue damage. This was accomplished by developing and validating a 
procedure for measuring microcirculatory blood flow and tissue oxygenation dynamics at 
multiple depths (up to 1 centimeter) using non-invasive DCS and DNIRS technologies. 
Due to the lack of pressure ulcer animal models that are compatible with our optical 
systems, a proof of concept was conducted in a porcine burn model prior to conducting 
clinical trials in order to assess the efficacy of the system in-vivo. A reduction in total 
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hemoglobin was observed for superficial (5%) and deep burns (35%) along with a 
statistically significant difference between the optical properties of superficial and deep 
burns (p < 0.05). Burn depth and viable vessel density were estimated via histological 
samples. 42% of vessels in the dermal layer were viable for superficial burns, compared 
to 25% for deep burns. The differences detected in optical properties and hemoglobin 
content by optical measurements correlated with the extent of tissue injury observed in 
histological stains. After proof of concept in animals, a human study was conducted and 
optical data was collected from 20 healthy subjects and 8 patients at risk of developing 
pressure ulcers. Blood flow index (BFI) values from the sacral region of patients were 
compared with those of healthy volunteers. Prior to loading measurements, baseline BFI 
values were measured in subjects in lateral position. These values were systematically 
higher for patients who developed open ulcers than for the other research subjects. While 
under the loading position, patients who developed a pressure ulcer had a decrease in BFI 
from baseline values an order of magnitude larger than healthy subjects (p < 0.01) and 
patients whose redness dissipated (p < 0.01). The hyperemic response, when pressure was 
released as the patient was moved back to a lateral position, showed a decreasing trend 
from one session to the next for patients who developed open ulcers. Overall, this work 
presents a novel non-invasive method of pressure ulcer assessment and provides an 
improvement over current assessment methods. The obtained results suggest the system 
may potentially predict whether non-blanchable redness will develop into an advanced 
pressure ulcer within four weeks from initial observation. 
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CHAPTER 1: INTRODUCTION 
1.1 Background and Motivation 
Generally, skin lesions such as burns and pressure ulcers have been associated with an 
extended length of hospital stay, local infection, sepsis, and mortality [1]. The ability to 
determine the depth and degree of cutaneous and subcutaneous tissue damage is essential 
for proper wound assessment and a significant factor for determining patient treatment. 
The current assessment tools used to determine which patients require aggressive 
interventions to prevent ulceration are based on qualitative factors such as a patient's 
mobility, nutrition, mental health, and incontinence. These qualitative tools do not 
include an objective assessment of the health of the skin and subcutaneous tissue at 
anatomical locations near bony prominences where ulcers are most likely to develop [2]. 
Many of the inputs to these scales are subjective and rely on the experience of the 
individual (usually a nurse) completing a questionnaire [3]. Therefore, a quantitative and 
objective method of tissue damage assessment (via tissue optical properties and blood 
flow) would be beneficial for improving patient outcomes, reducing hospital stays, 
properly classifying ulcer types, and directing treatment options. 
Clinical treatment protocols for skin ulcers are highly dependent upon the depth 
of tissue damage. Out of the five categories of pressure ulcers (PUs) defined by the 
National Pressure Ulcer Advisory Panel (NPUAP), stage I pressure ulcers represents the 
least severe category, while suspected deep tissue injury (SDTI) represents potentially 
severe damage to subcutaneous tissue [4]. In practice, it is difficult to differentiate stage I 
pressure ulcers from SDTI, particularly in patients with darker skin tones, because both 
manifest themselves as intact skin with redness or discoloration [5]. While stage I pressure 
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ulcers often heal spontaneously with no complications, the trauma and injury in the 
deeper tissue layers of patients classified as having SDTI are often severe and lead to 
significant morbidity. Unfortunately, to a clinician, the tissue damage of a SDTI will not 
be apparent until erythema in the skin is visible at which point significant tissue injury 
may already be present. Early detection of SDTI would allow the clinician to initiate 
aggressive off-loading therapies and stop the progression of tissue damage. 
Currently, clinicians subjectively classify pressure ulcers based on surface 
appearance and palpation. Qualitative risk-assessment tools such as the Braden, Norton, 
and Waterlow scales are routinely used to assess the likelihood of developing an open 
ulcer [2]. These assessment tools are based on factors such as a patient's cognitive 
functionality, ambulatory status, and nutrition but do not include an objective assessment 
of the health of the skin and subcutaneous tissue [2]. A detailed study of the scales used on 
PU assessment demonstrated that "none of the instruments tested achieved an optimal 
balance between sensitivity and specificity when identifying patients at risk for pressure 
ulcer development" [2]. Thus, a proper method for initial assessment is needed, given its 
significant impact on the duration and quality of the healing process. 
This research primarily focuses on the assessment of pressure ulcers and utilizes a 
porcine burn model in the validation process as an intermediary step in the absence of 
suitable pressure ulcer animal models that are compatible with our optical systems. 
Similarly to pressure ulcers, studies have shown that inexperienced surgeons incorrectly 
determine burn depth and tissue viability 50% of the time with that number still as high 
as 24-36% for experienced surgeons [6-8]. Clinical burn treatment protocol states to treat 
superficial partial-thickness burns non-surgically with antibiotics, while deep partial-
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thickness burns should be excised and grafted [9]. The difference in treatment protocols 
and the difficulty of distinguishing between different wound stages highlights the critical 
need for the accurate assessment of wound depth. 
1.2 Problem Statement 
Patients with limited mobility who are unable to off-load the weight of their body from 
pressure points over long periods of time are at a particularly high risk of ulcer formation. 
The outer appearance of internal tissue injury includes discoloration of intact skin as well 
as blistering. In practice, it is difficult to differentiate between these early changes and 
properly distinguish stage I PUs from SDTI. Current clinical assessment is both 
subjective and sub-optimal. Therefore, a quantitative method of tissue damage 
assessment would be beneficial for directing initial treatment options, improving patient 
outcomes, and reducing hospital stays. 
The purpose of this research is to utilize near infrared spectroscopy of the tissue at 
various depths below intact skin to assess tissue injury. Here, it is hypothesized that 
differences in tissue hemodynamics and blood flow can serve as useful indicators of 
tissue damage, differentiating healthy from damaged tissue. The importance of 
identifying viable tissue is well documented throughout the scientific literature [10-12]. 
Multiple groups have investigated the hemodynamics of brain tissue as it relates to tissue 
injury [13, 14]. Others have attempted to assess wound depth non-invasively [7, 8, 15]. 
However, to the author’s knowledge, no group has attempted to characterize tissue 
damage from optical data of existing subcutaneous ulcers with intact skin.  
A major focus of this work involved the use of non-invasive optical technologies 
to differentiate superficial from deep wounds and provide quantitative assessment of 
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tissue viability to direct treatment options. The research idea evolved from a previous 
study by the author’s research team using a frequency-domain diffuse near infrared 
spectroscopy system. The device was capable of measuring the optical absorption and 
reduced scattering coefficients (µa and µs’), oxyhemoglobin [HbO2], and 
deoxyhemoglobin [Hb] concentrations of tissue. The four year study demonstrated that 
the temporal change in [HbO2] within diabetic foot ulcers (measured at depths of 4-6 
mm) was a predictor of healing (93% sensitivity, 88% specificity) [16]. It was then 
postulated that the assessment of tissue injury via similar optical methods could be a 
possibility. 
The initial step towards the proposed research was the development and 
calibration of an optical system with increased spatial resolution for interrogation of 
specific tissue volume depths. After construction, in-vitro validation and calibration of 
the system were conducted using optical phantoms with known properties. The 
functionality of the system was then tested in-vivo using a porcine wound model. Upon 
completion of the animal study, a clinical trial was conducted to test the clinical 
performance and ease of use of the device. 
1.3 Objectives 
The overall goal of the proposed research was to develop a method for assessing the 
extent of tissue damage underneath intact skin using non-invasive optical systems, and to 
investigate the correlation between tissue optical properties and tissue viability. The main 
hypothesis underlying this research was that (a) changes in tissue oxygenation and/or 
microcirculatory blood flow measurable by Diffuse Near Infrared Spectroscopy and 
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Diffuse Correlation Spectroscopy differ between healthy and damaged tissue and (b) the 
magnitude of these changes differs for varying degrees of tissue damage.  
Accordingly the specific aims of this research are: 
Specific Aim 1: Develop and calibrate non-invasive Near Infrared Systems (DNIRS & 
DCS) to assess tissue optical properties and hemodynamics (specifically microcirculatory 
blood flow and tissue oxygenation) at multiple tissue volumes or depths. This aim was 
broken down into the following steps. 
Sub aim 1.1: Re-design a Diffuse Near Infrared Spectroscopy device and modify 
an existing Diffuse Correlation Spectroscopy system for tissue characterization at 
multiple depths. 
Sub aim 1.2: Calibrate the optical systems in-vitro via liquid and silicone 
phantoms. 
Sub aim 1.3: Validate the efficacy of the system to differentiate tissue damage at 
two different depths utilizing an in-vivo porcine burn model.  
Specific Aim 2: Using the systems described in Aim 1, assess the health of tissue layers 
in patients with tissue injury by correlating tissue oxygenation and blood flow before, 
during, and after induced ischemia with the development of open pressure ulcers. 
Sub aim 2.1: Evaluate normal values of tissue oxygenation, hemoglobin content 
and blood flow by analyzing optical data of healthy subjects. 
Sub aim 2.2: Evaluate values of tissue oxygenation, hemoglobin content and 
blood flow to differentiate between tissue injury and healthy tissue by recruiting 
patients with non-blanchable redness on intact sacral skin and comparing the 
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optical data of the patients who develop open pressure ulcers with data from 
patients whose skin remains intact for at least 4 weeks. 
This thesis is organized in the following way. First, as shown above, there is a definition 
of the overall objectives and specific aims. Next there is an overview of tissue injury and 
a brief introduction to pressure ulcers. Chapter 3 consists of a review of optical 
methodologies for tissue injury assessment. Chapter 4 focuses on the background, design, 
and calibration of the optical systems being used. Chapter 5 describes the in-vivo 
validation of our system for differentiation of superficial and deep tissue injury using a 
porcine burn model. Chapter 6 describes the design and results of the pressure ulcer 
human study; and finally, chapter 7 details the overall conclusions and proposed future 
work. 
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CHAPTER 2: CHARACTERISTICS OF TISSUE DAMAGE 
This chapter provides a brief summary of tissue injury as it relates to skin lesions, 
specifically burns and pressure ulcers. Multiple parameters are used as markers of tissue 
injury including (but not limited to) the presence of radical and reactive oxygen species, 
ischemia, and mechanical trauma [17]. In this thesis, tissue damage is defined as damage to 
body tissue which causes a disability in functioning and possible change in appearance 
from normal healthy tissue. Chemical alterations of biological tissue, either through 
reactive intermediates or toxicities, as well as injuries induced by electrical contact will 
not be covered in this chapter. 
2.1 Healthy Skin 
Prior to discussing tissue injury as it relates to skin lesions, it would be beneficial to 
obtain a general understanding of the structure and functionality of healthy skin tissue. 
Healthy skin is defined as viable tissue which can perform its intended essential functions 
while maintaining proper homeostasis. It is well known that skin is the largest organ of 
the body, both in terms of its weight and surface area [18]. Among its multifaceted 
functions, it provides a protective barrier between the inside tissues of the body and many 
different environmental insults such as pathogens, ultraviolet radiation, and mechanical 
trauma. In addition, the skin protects the body from water loss, helps regulate metabolism 
and body temperature through sweat glands, participates in calcium homeostasis by 
contributing to the body's supply of vitamin D, and senses our surroundings through 
nerve endings that alert of potential danger by detecting pressure, pain, heat, and cold [19]. 
Structurally, healthy skin tissue is composed of an upper layer called the 
epidermis and a nutritive support network underneath called the dermis. The epidermis is 
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responsible for most of the barrier functions of the skin, keeping essential body fluids in 
and dangerous pathogens out. The outermost layer of the epidermis (the stratum 
corneum) consists of keratinized cells which are constantly replaced by new cells 
manufactured in the lower (basal) layer of the epidermis. As the new cells are pushed 
upwards towards the outside environment they harden, die, and are shed overtime [19]. 
Furthermore, the epidermis also contains melanin producing melanocytes, which 
participate in skin pigmentation in response to ultraviolet light exposure. Melanin can 
absorb energy from ultraviolet light in order to protect underlying tissue from damage. 
Finally, Langerhans cells are involved in epidermal immunity while Merkel cells function 
as mechanical sensors and produce growth factors that regulate hair and nail growth, 
sweat glands, and nerve function in skin [20]. 
The dermis is the inner layer of healthy skin and can vary in depth from 0.3 mm 
to 4 mm depending on body location and generally speaking is at least ten times thicker 
than the epidermis [21]. This layer contains blood vessels, nerves, hair follicles, sweat 
glands and oil glands; yet nearly 75% of its weight is due to a matrix of collagen and 
elastin fibers which provide elasticity as well as some structural support [20]. It provides 
integrity and flexibility to the skin while supplying nutrients to all skin layers. Although 
thicker, the dermis has less cell density than the epidermis. Some of the cells found in the 
dermis include fibroblasts for collagen synthesis, immune cells such as monocytes and 
macrophages, and dermal dendrocytes which contribute to skin defense and modulate 
injury responses [20].  
Due to its elasticity, healthy skin requires a structural framework of connective 
tissue commonly referred to as the subcutaneous layer. The orientation of the connective 
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tissues beneath the dermis plays a key role in both skin tissue appearance and function 
[18]. All connective tissue is composed of three major classes of biomolecules: structural 
proteins (collagen and elastin), specialized proteins (fibrillin, fibronectin, and laminin), 
and proteoglycans [18]. The subcutaneous layer is mostly composed of adipose tissue but 
also contains blood vessels, nerves, cartilage, muscle, bone, tendons and ligaments. 
Adipose cells provide structural support and mechanical cushion to protect from injury, 
assist in thermoregulation by acting as insulators, and allow for energy storage. Figure 1 
shows the structural composition of healthy skin and connective tissues. 
 
Figure 1: Structural composition of healthy skin tissue. Reprinted from Reference [22].  
 
 
 
Now that a general understanding of healthy skin tissue has been established, the 
following section will attempt to define tissue injury as it relates to pressure ulcers and 
burn wounds.  
2.2 Pressure Ulcers 
According to the NPUAP, a pressure ulcer is a localized injury to the skin or underlying 
tissue caused by a combination of consistent pressure with shear stress and/or friction 
which results in the disruption of blood supply to the microvasculature. Often called 
decubitus ulcers, bedsores, or pressure sores, these wounds impede the flow of oxygen 
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and nutrients to the capillary network and can range from mild superficial redness to 
severe damage with exposed muscle and bone. In order to cause flow impairment, local 
ischemia, and eventual tissue damage, the applied pressure must be greater than arterial 
capillary pressure, and often occurs over bony prominences.  
The most widely used pressure ulcer classification system in the United States 
defines five categories for classifying PUs: stage I, II, III, and IV pressure ulcers, which 
refer to surface injuries of increasing depth and severity, and suspected deep tissue injury, 
which describes a discolored area of purple or maroon intact skin resulting from damage 
to underlying tissue. Clinicians also tend to use the term ‘unstageable’ to refer to full 
thickness tissue loss in which actual depth of the ulcer is completely obscured by slough 
(yellow, tan, gray, green or brown) and/or eschar (tan, brown or black) in the wound bed. 
Until enough slough and/or eschar is removed to expose the base of the wound, the true 
depth, and therefore stage, cannot be determined. Figure 2 shows a graphical 
representation of the different stages of pressure ulcers. 
 
Figure 2: Graphical representation of pressure ulcer classifications including stages 1-4, suspected 
deep tissue injury (SDTI) and unstageable pressure ulcers. Imaged modified from Reference [23]. 
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There are two hypotheses that describe how pressure ulcers propagate based on 
histological and pathological data [24-26]. In the more traditional top-to-bottom hypothesis, 
ulcers start as damage to the microvessels of the upper dermis and spread to subcutaneous 
tissues if external pressure is not relieved. In contrast, the bottom-to-top hypothesis 
suggests that ulceration begins in subcutaneous skeletal muscle and propagates upward to 
the skin, because the high metabolic activity of muscle makes it more sensitive to 
ischemia than skin [26]. The theory of suspected deep tissue injury (SDTI) has been 
developed on the basis of this second pathway in which ulcers can develop within 24 
hours from initial pressure, yet take as long as a week to become visibly apparent [24, 27]. 
This delay of visual evidence often results in the misdiagnosis of damaged tissue by 
current standard assessment tools which rely on visual examination instead of the 
assessment of the health of underlying tissue.  
It is conceivable that some ulcers form top-to-bottom and others form bottom-to-
top; the optical method investigated herein provides information about tissue health at 
both superficial and deep depths, enabling the diagnosis of either ulcer type. The 
formation of pressure ulcers via either of the two pathways is generally considered to be 
the result of a combination of factors including cell deformation, impaired lymphatic 
drainage, reperfusion injury, and ischemia [28]. For the purpose of this research ischemia 
will be defined as the reduction in arterial flow which provides an oxygen supply 
insufficient to match the oxygen demand of the surrounding tissue [29]. Bioengineering 
studies have suggested that deformation plays a role in the damage process over short 
durations of pressure exposure while ischemia and reperfusion increase over time and 
become dominant factors for prolonged exposures [30]. Another published review of 54 
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studies by Coleman et al, identified skin/ulcer status, mobility, and perfusion as the three 
most frequent and significant risk factors [31]. The increased impact of ischemic tissue on 
ulceration along with considerable evidence linking blood vessel damage to pressure 
ulceration [24-26, 32-38] makes the measuring of blood flow dynamics an ideal parameter for 
the investigation of individuals at risk of ulcer development. The sites most prone to 
pressure ulcer development include the sacrum, heels, outer pelvic outlet, proximal end 
of the femur, and lateral malleoli [39]. Only sacral tissue damage was assessed during the 
clinical study described on Chapter 6 of this thesis due to the higher incidence and ease of 
accessibility with our system. 
Overall, pressure ulcers pose a significant economical burden in society. The 
estimated cost of managing a single full-thickness pressure ulcer can be as high as 
$120,000, while the total annual cost of treatment for all pressure ulcers in the U.S. is 
estimated to be $11 billion [40, 41]. These ulcers cause considerable harm to patients in 
acute care, long-term care, and rehabilitation facilities, hindering functional recovery 
while frequently causing pain and the development of serious infections [40]. In addition, 
the health-related quality of life of those who suffer from pressure ulcers is greatly 
diminished by the inability to participate in social activities, disturbed sleep, and reduced 
feelings of self-confidence [42]. Nearly 60,000 U.S. hospital patients are estimated to die 
each year from complications due to hospital-acquired pressure ulcers [43]. In hospitals, 
patients develop pressure ulcers due to the lack of mobility while the patient is being 
treated, whether in a wheelchair or bed. After only 2 weeks of hospital admission, 80% of 
high risk patients develop a pressure ulcer with that number increasing to 96% after 3 
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weeks [43]. As the baby boomer population ages, more patients will enter the rating of 
high risk, making this a serious contemporary issue.  
2.3 Burns 
Due to the usage of a porcine burn model, the characteristics of burns are briefly 
addressed in this chapter. Burn injuries can be conceptually described in terms of severity 
(degree), percentage body area burned, and agents involved (e.g. fire, hot fluids, 
electricity, etc) [44]. The severity of a burn injury is determined by three main factors: 
extension/location, age, and burn depth [45]. Out of these three factors, burn depth is often 
used to classify burns into four groups: First degree burns, superficial dermal (partial-
thickness) burns, deep dermal (partial-thickness) burns, and full-thickness burns [46]. First 
degree burns correspond to sun burns which usually heal without medical intervention 
and do not often make it to the Burn Unit. Thus, in clinical practice, only the three latter 
groups are relevant.  
The mechanisms of injury by which burns can be classified due to their causative 
agents including fire, hot surfaces or liquids, chemicals, lasers, radiation and electricity. 
Hot surfaces were the only mechanisms of burn injury utilized during this research study 
due to the ability to reproduce specific burn areas and depths. Regardless of causative 
agent, burn injuries tend to causes both local skin damage and generalized effects on the 
body. Tiwari et al present a detail account of the systemic and local damage observed 
after a burn injury [47]. He describes a generalized increase in capillary permeability 
which causes plasma to leak out from capillaries into interstitial spaces. This leakage 
could persist for 48 hours until the permeability returns to normal or the capillaries are 
thrombosed and become completely occluded. He further describes that loss of plasma is 
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often the cause of hypovolemic shock in burns and the amount of fluid loss depends on 
the extent of the burn injury. Blood loss is also proportional to the extent of tissue 
damage as red blood cells are lost in thrombosed vessels underlying the burned skin. 
Wallace’s rule of ‘9’ is usually used in adults to calculate the total body surface area 
(BSA) burned by assigning a BSA value of 9% to each major body part. Lund and 
Browder's charts are used in both adults and children since they compensates for the 
variation in body shape with age and therefore can give an accurate assessment of the 
burned area in children [48].  
Overall, burns have been associated with an extended length of hospital stay, 
pain, local infection, sepsis, gas gangrene, and mortality with an estimated annual total 
cost of treatment in the US of $7.5 billion [49]. The 2015 fact sheet from the American 
Burn Association estimates the yearly incidence of burn injuries in the US at 486,000 
patients, resulting in approximately 3,200 deaths. Worldwide, it is estimated that 6.6 
million burn injuries occur each year with more than 300,000 burn-related deaths, and 
that many more people are seriously disabled or disfigured due to burns [50]. As with 
pressure ulcers, the initial injury assessment and treatment selection has a significant 
impact on the duration and quality of the healing process. Treatment decisions for both 
burns and pressure ulcers depend on the extent of tissue injury; yet, due to a lack of 
diagnostic tools, current treatment decisions are often made without knowledge of 
underlying tissue quality and heavily depend on physicians' subjective assessments [8, 49]. 
Due to the socio-economical burdens of these wounds recent attention has been allocated 
to the prevention and early detection of latent tissue damage. In the following section the 
existing optical modalities for the assessment of tissue injury are explored. 
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CHAPTER 3: REVIEW OF OPTICAL METHODS FOR THE ASSESSMENT OF 
TISSUE INJURY 
3.1 Introduction 
Multiple non-invasive technologies are in existence which provide information about skin 
damage at superficial depths. While non-optical imaging techniques such as MRI, CT and 
high frequency ultrasound can provide information from subcutaneous depths, they are 
not practical for rapid and cost-effective assessment of tissue damage [51-55]. None of 
these technologies are commercially available as burn or pressure ulcer assessment tools 
and have not gained clinical acceptance because of limitations in data quality, ease of use, 
or the practicality of using the device in a clinical environment.  
The purpose of this chapter is to provide a brief introduction of optical 
technologies used for the assessment of tissue injury, either commercially available or for 
research purposes, and to explore their limitations for assessing pressure ulcers. The 
technologies described below are Laser Doppler Imaging, Laser Speckle Contrast 
Imaging, Thermography, Optical Coherence Tomography, Hyperspectral Imaging, 
Orthogonal Polarization Spectral Imaging, Confocal Microscopy, and finally Spatial 
Frequency Domain Imaging. For this section, cited publications were limited to those 
involving optical technologies that have been validated in human studies, with the 
exception of spectral frequency domain imaging due to its relevance to this research. 
After the review of current optical modalities, the optical systems used in this research 
are described in Chapter 4. 
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3.2 Laser Doppler Flowmetry and Imaging 
Laser Doppler perfusion monitoring (LDPM) and laser Doppler flowmetry are the oldest 
Doppler based techniques used for the assessment of burn depth [1]. These modalities rely 
on the Doppler principle which describes how a mono-frequency incident light beam 
experiences a change in frequency when scattered by moving objects. As coherent laser 
(monochromatic) light is directed to a tissue sample via optical fibers, the photons are 
scattered by moving objects in the tissue (e.g. red blood cells) and undergo a frequency-
broadening shift which is proportional to the amount of microvascular blood flow in the 
tissue [56] [57]. Using a detector fiber, backscattered light is transported to a photodetector 
where the spectrum of frequency shifts is detected in arbitrary numbers of volts. 
Algorithms are used to convert the frequency shifts into Laser Doppler Flux (LDF) 
indices which are proportional to the average velocity and number of red blood cells 
within the probed tissue volume [58]. The depth of microcirculation assessment below the 
point of probe-tissue contact depends on the wavelength of light, tissue optical properties, 
and source-detector separation [59]. Typically the wavelengths of light used range from 
630-830 nm and measure tissue depths of roughly 0.5-1.0 mm [58]. 
 
Figure 3: A schematic diagram of an LDI system. Reprinted from Reference [60]. 
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The accuracy of Doppler flowmetry in the diagnosis of burn depth ranges from 
90-97%, compared to 66% for clinical evaluation alone [61]. In addition, studies have 
suggested a positive predictive value as high as 98.4% [62]. Nevertheless, technical 
limitations render the technology suboptimal as only part of the total burn surface can be 
assessed at a time; making assessment of large wound areas lengthy and cumbersome 
while introducing the risk of erroneous diagnosis due to sampling error [63]. Moreover, a 
heated probe is often used in direct contact with one or more points of the burn surface in 
order to stimulate flow, increasing the potential for pain, trauma to already vulnerable 
tissue, and sepsis secondary to contamination [1, 61]. 
Laser Doppler imaging (LDI) and laser Doppler perfusion imaging (LDPI) 
overcome the limitations of flowmetry by utilizing noncontact scanning techniques 
involving lenses and mirrors for the delivery of light to and from the sampled tissue, as 
depicted in Figure 3. This allows for the creation of two-dimensional LDF maps over the 
entire burn wound surface [61]. In addition, by avoiding direct tissue contact, LDI and 
LDPI minimize patient discomfort, infection risk, and tissue microtrauma [1]. After 
scanning a burned area, LDI devices generate a color-coded perfusion map that 
corresponds to varying burn depths as observed in Figure 4. 
 
Figure 4: Color-coded perfusion map from an LDI system of a hot water burn on the skin of a 
patient. An outline of the burn wound (A) and deep burned areas indicating low perfusion (B and C) 
is shown. Reprinted from Reference [64]. 
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Laser Doppler imaging is the only technique that has been approved by the 
American Federal Drug Administration (FDA) specifically for the assessment of burns. 
Commercially available systems can create a 256x256-pixel blood flow image in about 5 
minutes with a 1mm spatial resolution [58]. Full field systems have been developed which 
can produce a 480x480 [64] and even 1024x1024 [65] pixels image, yet these systems often 
include a compromise between imaging speed, measurement accuracy, and imager 
performance. The technique was first used by Niazi et al. [66] who demonstrated LDI 
assessment was comparable to biopsy-histology. Pape et al. [67] reported a 97% accuracy 
of burn depth assessment utilizing LDI. Hoeksema et al. [68] reported similar findings, 
stating LDI accuracy to be 95% and 97% for LDI scans performed on day 3 and day 5 
after burn compared to 52.5% and 71.4% for clinical evaluation. A study by Jünger et al. 
indicated that LDI could be used to distinguish healthy from diseased microcirculatory 
responses in venous ulcers [69].  
Laser Doppler perfusion measurements were also used in a 2001 study by Timar-
Banu et al. to assess perfusion in chronic wounds of mixed etiology (4 diabetic foot 
ulcers, 10 venous leg ulcers, and 1 pressure ulcer) where increased LDF values in 
granulation tissue were reported when compared to intact skin [70]. In a 2005 study, Nixon 
et al. assessed the validity of the clinical grading of erythema by comparing stage I 
pressure ulcer grades derived from clinical observation with measurements of skin 
perfusion [71]. The sacrum and buttocks of 37 surgical in-patients were measured and a 
statistical difference in blood flow was observed between skin with blanchable, non-
blanchable, and no redness. High blood flow of different intensities characterized 
blanching and non-blanching erythema while lower flow was observed in skin with no 
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redness. However, the authors acknowledged that practical difficulties in performing LDI 
measurements limited the sample size and although three areas were assessed clinically 
(sacrum, left buttock, and right buttock), image analysis summarized each scan as one 
single scan and compared it to the worst of three grades allocated clinically.  
Although an improvement from laser Doppler flowmetry, laser Doppler imaging 
modalities still have their limitations. Due to differences in the algorithms used for the 
calculation of relative perfusion indices, flux values are calculated in arbitrary units. 
These arbitrary units make it difficult to compare results across multiple systems or by 
different research teams. In addition, the exposure to ambient light or specular reflections 
due to surface moisture and tissue curvature can result in signal loss [72]. Furthermore, this 
technology requires patients to remain motionless for the duration of the measurement 
session (up to 5 minutes) while exposing the area of damage to the noncontact system. In 
a clinical setting this can prove to be very difficult, resulting in motion artifacts during 
image acquisition, which can ultimately lead to misdiagnosis. The practical difficulties of 
performing LDI measurements in critically ill, elderly, and immobile patients make this 
modality impractical for clinical assessment of early onset pressure ulcers. 
3.3 Laser Speckle Contrast Imaging (LSCI or LSI) 
Laser speckle is a light phenomenon which occurs when biological tissue is illuminated 
by coherent laser light [73]. The laser speckle forms due to irregularities in tissue structure, 
which create constructive (light) and destructive (dark) interference patterns as the laser 
light is irregularly backscattered [74]. Laser speckle contrast imaging (LSCI or LSI) is a 
laser-based imaging technique which utilizes laser speckle images to study perfusion. 
Figure 5 shows a typical LSCI set up. Moving particles within tissue, such as blood cells, 
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introduce dynamic changes to the speckle patter which can be detected by a CCD camera 
[75]. The moving blood cells produce blurring of the image and the speckle changes are 
averaged over a given exposure time of the camera to quantify speckle contrast. Increased 
blood flow will increase image blurring and lower contrast [73], which is measured as the 
ratio of standard deviation to the mean grayscale intensity in a square of pixels (e.g., 5×5 
pixels), thus representing the average speed and volume of moving particles (e.g., red 
blood cells) in that square [76]. As a result, LSCI creates a color-coded map similar to LDI 
without the prolonged scanning time. 
 
Figure 5: Basic setup for an LSCI system. Reprinted from Reference [76]. 
Although both LDI and LSCI are related methods used for the measurement of 
perfusion, they rely on different physical principles and have different data sampling 
techniques. Unlike the one-dimensional scanning of LDI, LSCI expands a laser output to 
a large two dimensional shape to examine a full-field, rather than a single point; enabling 
fast whole tissue measurements with high sampling rate [73, 77]. However, LSCI has a 
more superficial depth of measurement at about 300-500 µm compared to the 1–1.5 mm 
measuring depth of LDI [78]. On skin, LDPI measures deeper, faster flowing vessels while 
LSCI measures the more superficial slower flowing vessels; thus, giving different results 
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[73]. Nevertheless, like LDI, LSCI measures average velocity and data are presented in an 
arbitrary unit. 
Historically, laser speckle contrast imaging has been used to derive full-field, 
two-dimensional maps of blood velocity, as depicted in Figure 6 [77]. One study used a 
laser speckle imager with a 633 nm HeNe laser source on a Duroc pig model to study 
cutaneous deep dermal wounds [74] and scar perfusion over time [79]. It was shown that 
LSCI data could be used for wound depth grading and that blood perfusion tends toward 
lower values as the wound healing process advances. In the 1980s, Briers and Fercher 
made the first laser speckle photography clinical measurements on retinal perfusion [80] 
and later developments led to real-time perfusion imaging with LSCI [81, 82]. LSCI has 
also been proven useful in functional tests of skin microcirculation [1]. Studies of burn 
injuries have correlated faster healing times with increased perfusion in the first week 
post-injury assessed with LSCI [83].  
 
Figure 6: Laser speckle contrast image on a human liver. The color scale represents relative blood 
flow levels. Reprinted from Reference [73]. 
The fast measuring times of LSCI are ideal for measurements of the 
microcirculation over large areas, making it suitable for dynamic functional tests which 
require high temporal resolution. Its non-contact nature, however, make it sensitive to 
movement artifacts [84]. In addition, LSCI devices require constant calibration prior to 
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measurements due to the presence of a biological zero signal, which refers to the non-
zero output signal of the device due to noise in the speckle signal even during complete 
flow occlusion [73]. The noise has been attributed to local redistribution of blood cells 
within the vessels and Brownian motion of the molecules [78], yet interpretation is 
debatable and proper handling of the biological zero requires further investigation [85, 86]. 
Furthermore, LSCI signals are based on the average velocity and concentration of RBCs, 
thus, values cannot be given in absolute numbers and are limited to relative 
measurements. 
Commercially available FDA-approved systems such as the MoorLDI2 (Moor 
Instrument, Ltd), utilize LSCI to offer “an aid to burn wound management”. The systems 
are able to measure superficial blood flow but offer small spatial resolution with a 
maximum penetration depth of less than 0.5 mm according to the manufacturer’s 
specifications. Although useful, LSCI is still a qualitative tool [87], which may be prone to 
misinterpretation and misdiagnosis. While studies have been conducted in animals to 
assess the usefulness of LSCI for the assessment of pressure-induced ischemic ulcers [88], 
studies assessing pressure ulcers in humans are scarce and require further investigation.  
3.4 Thermography or Thermal Imaging 
Thermography, or thermal imaging, involves the measurement of naturally emitted 
thermal (infrared) radiation from the wound under examination as an indicator of its 
depth [63]. This technique is based on the notion that superficial wounds are warmer than 
deeper ones due to increased vascular perfusion near the wound surface; thus, enabling 
medical professionals to inversely correlate wound depth with temperature [63]. The 
emissive power (Eb) of a blackbody strongly depends on its temperature (T), according to 
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the Stefan-Boltzamn law Eb = σT4, where σ is the Stefan-Boltzmann constant [89]. Human 
skin has an emissive power similar to that of a blackbody (an idealized physical body that 
absorbs all incident electromagnetic radiation, regardless of frequency or angle of 
incidence) in the 2-14 μm wavelength range [90]. Thermographic measurements of the 
skin are processed to create color-coded images that express the relative skin temperature 
over a defined area. 
 
Figure 7: A schematic diagram of a thermal imaging system. The focal plane array (FPA) is arranged 
in a vacuum chamber to provide temperature maps of the measured object. Reprinted from 
Reference [89]. 
In thermography, an array of infrared detectors is arranged in the focal plane of a 
lens, as shown in Figure 7, and can provide temperature maps with an estimated spatial 
resolution of 2-4 mm [91] and temperature resolution near 0.1ºC [92]. Detectors must be 
calibrated using objects with known temperatures to obtain an absolute measurement of 
temperature. Due to the high absorption coefficient of tissue at infrared wavelengths, 
emitted radiation from deeper tissue does not reach the surface; thus the temperature 
maps developed by thermal imaging systems reflect the radiation at the surface of the 
epidermis [89]. Active dynamic thermography (ADT) is an advanced thermal imaging 
technique which involves the recording of steady state temperatures using a standard 
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infrared camera following thermal excitation of the tissue by a light source (typically 
halogen lamps). Upon thermal excitation, a second set of measurements is taken and the 
thermal diffusivity of tissue components and wound regions are quantified [77]. Liquid 
crystal thermography (LCT) is another technique involving the uses of a plate of 
thermochromic liquid crystals to measure temperature distributions in tissue. The crystals 
absorb the thermal radiation of tissue and the plate provides a spectrum of colors which 
correlate with temperature readings, as shown in Figure 8 [77]. 
 
Figure 8: The thermographic image of a patient's leg (a) is shown next to a photograph of the same 
leg (b) to display temperature readings using a spectrum of colors. Reprinted from Reference [90]. 
Over the years, the application of thermography as a thermal radiation 
measurement technique has been expanding in the healthcare field. In the early 1960s, 
Lawson et al. reported 90% accuracy when using infrared scanning to predict burn depth 
as confirmed by histology [93]. Subsequent studies suggested thermographic evaluation of 
burn depth could predict whether the burn heals spontaneously in 3 weeks or requires 
excision and grafting [94, 95]. Moreover, in 1972, Watson and Vasilescu found full 
thickness wounds to be more than 2 °C cooler than contra-lateral unburned skin [96] 
opening the possibility of burn classification via thermography. Recent studies have 
reported using high-resolution digital infrared cameras to assess burn depth with higher 
specificity, differentiating between full thickness, deep partial thickness, and superficial 
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partial thickness burns [97-99]. The ADT method previously described could also be used to 
evaluate burn depth. Studies comparing standard thermographic techniques with the ADT 
method via histological evaluation conclude that ADT has superior accuracy, specificity 
and sensitivity for the classification of burn depth [100, 101]. However, a common general 
problem with thermography is the distortion in image caused by evaporative water loss in 
the wound bed [102]. This could be resolved by letting the burn dry completely but would 
consequently increase the overall assessment time [77]. Applying a nonpermeable covering 
to the wound bed would allow immediate assessment [77], yet this approach could be 
potentially painful and increases the risk of contamination. In addition, granulation in the 
wound bed can compromise measurement accuracy, thus optimal results are obtained 
within 3 days of burn injury. This precludes the use of thermography on patients who are 
transferred beyond the three days window [1]. 
The potential of thermal imaging for pressure ulcer classification was investigated 
as early as 1973. Using thermography, Barton et al. observed a temperature difference 
from surrounding tissue of less than 1 °C for slow healing pressure ulcers and up to 
2.5 °C for normal healing ulcers [103]. In 1981, Newman and Davis captured thermal 
images of the intact sacral skin of 91 patients upon admission to a geriatric unit and found 
that thermographic abnormalities were predictive of sacral pressure ulcer formation [104]. 
Thermography has also been used to classify pressure ulcers by healing potential, with 
higher temperatures at the wound site suggesting impaired healing when compared to the 
temperature of surrounding skin three weeks after ulcer formation [92, 105]. Similarly, 
Chaves et al. utilized thermography to evaluate the healing of pressure ulcers by 
comparing four pressure ulcer patients receiving standard treatment to four pressure ulcer 
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patients receiving additional LED phototherapy. A temperature difference of up to 7.6% 
was found between the two groups, with phototherapy treated ulcers having higher 
temperatures than non-treated ones [106]. In addition, Judy et al. reported the use of 
thermography for predicting the anatomical location of ulceration prior to wound 
formation with higher accuracy than the Braden Scale [107]. 
Although thermal imaging provides an easy to use modality with technical 
validity, difficulties in patient/camera positioning, visual/thermal image registration, 
ambient heat loss, sensitive timing, and lack of quantitative tools are reported as 
confounding limiting factors for clinical routine assessments [61, 63, 77]. 
3.5 Optical Coherence Tomography 
Optical coherent tomography (OCT) is a non-invasive imaging technique which uses the 
principles of low-coherence interferometry to assess tissue microstructure and function 
[108]. OCT systems produce high resolution two or three-dimensional cross-sectional 
images of tissue structures by analyzing backscattered laser light from the interrogated 
sample [77]. In most OCT systems, a broad-band NIR light source (800-1800 nm) is 
pulsed through an angled 50:50 beam splitter that transmits 50% of the light and reflects 
the other 50% as shown in Figure 9. Out of the two resulting beams, one is directed to the 
tissue sample using a lens assembly to focus the light onto the skin. The second beam is 
directed at a reference mirror. The light from the reference mirror propagates directly 
back to the beam splitter with no time delay; however, the light that is reflected and 
backscattered from the sample has a time delay due to the optical properties of the tissue. 
The two reflected light waves are recombined at the beam splitter and superimposed into 
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a single light wave to generate an interference pattern which is registered by a 
photodetector [77, 108, 109]. 
 
Figure 9: A schematic of a typical OCT system. Reprinted from Reference [108]. 
  The interference pattern of the superimposed beam indicates where the waves are 
in phase (signal amplification) or out of phase (signal nullification), providing 
information about how long the light took to travel into the sample and be reflected. The 
axial scan depth is controlled mechanically by moving the reference mirror across the 
tissue sample with light source wavelengths between 1300 nm and 1800 nm providing 
the best penetration depth [110]. Image reconstruction is achieved by obtaining multiple 
axial (depth) measurements and computational analysis is used to obtain information 
about the microstructure of the sample [111]. The resolution of the images is typically on 
the order of 10-20 microns, but recent advances have led to resolutions approaching 1 
micron [110, 112].  
Polarization sensitive optical coherence tomography (PS-OCT) is a modification 
of OCT which provides measurements of alterations in the polarization state of polarized 
light in addition to structural images [110, 112-114]. Under normal conditions, undamaged 
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collagen exhibits birefringence; that is, it is capable of splitting light into two rays which 
are polarized perpendicularly to one another. When thermal injury occurs, collagen is 
denatured and loses this property [115]. PS-OCT quantifies tissue damage by assessing the 
degree of change in polarization (or phase retardation angle) in reflected light. The phase 
retardance of tissues at different tissue levels can be quantified to discriminate injured 
from uninjured tissues while a reduction in collagen birefringence is thought to be related 
to burn depth. 
Animal studies show a statistically significant correlation between PS-OCT 
measurements and absolute burn depth with accuracy comparable to histological 
analysis [114, 116]. Similarly, in a study of partial-thickness wounds in porcine skin, OCT 
was used to visualize and measure the thickness of re-epithelialized skin [117]. PS-OCT 
has also been used to quantify collagen damage ex vivo in burned human skin [118] and to 
evaluate tissue morphology and structure of skin equivalents compared to histology [119]. 
Jiao et al. used Mueller matrix OCT, an extension of PS-OCT, to separate phase-based 
polarization contrast from amplitude based contrast and improve the detail of information 
obtained from tissue [120]. A few years later, Mueller matrix OCT was further modified by 
Todorovic et al. for burn wound imaging through the use of continuous source 
polarization modulation [121]. Ultrahigh Resolution OCT has been shown as a detailed 
non-invasive metric of wound healing as it allows for identification of wound 
composition, wound size, epidermal migration, and dermal-epidermal junction formation 
[122]. The potential of PS-OCT measurements for the study of abnormal wound healing 
and wound treatment evaluation has also been shown by quantifying healing through the 
assessment of collagen content and fiber orientation [113]. 
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Clinically, OCT could prove useful for the assessment and study of both burn and 
chronic wounds. Kim et al. has used a combination of microvascular measurements and 
birefringence data to characterize burn depth in humans [123]. The study suggested that 
PS-OCT may allow for earlier burn depth detection than current standards, and indicated 
the potential cost savings of such methods. Additionally, OCT may be used to monitor re-
epithelialization, as it is able to differentiate between the epidermal and dermal layers [117, 
124]. Furthermore, serial imaging of full-thickness wounds allowed changes in wound 
morphology to be followed throughout the healing process, and in one study the 
integration of collagen implants into healing wound tissue could be visualized using OCT 
[125]. 
The non-invasive optical measurements offered by this technique are preferable to 
invasive biopsies that may interfere with the healing process of a wound. However, OCT 
has a low depth resolution due to the fact that it scans all z-axis points instantaneously, 
meaning the only limiting factor is the pulse rate of the interferometer [109] which allows 
for penetration depths of approximately 1 to 2 mm. In addition, OCT must be able to 
differentiate burn wound depths with high accuracy and repeatability in order to be of use 
to the clinician. This modality is entirely dependent on the structure of collagen, instead 
of microvasculature, for burn depth assessment; which does not take into account effects 
of chronic dehydration and collagen production on wounds that have not been thermally 
injured. Translation of OCT and PS-OCT to the clinical environment is promising yet 
uncertain due to the lack of published human studies in this area. Nevertheless, the 
clinical potential of this modality may become more feasible in the future with the advent 
of technology and improvements in opto-electronics. 
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3.6 Hyperspectral Imaging 
Hyperspectral imaging (HSI) is an optical modality in which spectral analysis of reflected 
light is performed to obtain information about cutaneous tissue oxygenation in the skin. 
The use of HSI for tissue damage assessment comes from the notion that necrotic tissue, 
scarring, and dermal oxygen saturation alter tissue absorption [126]. In hyperspectral 
imaging, a broadband light source (typically between 500 and 700 nm) is used to 
illuminate the skin being interrogated [77]. Similar to other spectroscopic imaging 
systems, a combination of a CCD camera and a tunable optical filter collects 
backscattered light from the illuminated tissue at different wavelengths. The filter uses an 
electronic controlled tuner to rapidly scan between multiple wavelengths of interest while 
the camera collects intensity levels at each wavelength and stacks the images. Therefore, 
the system provides an absorption spectrum for each pixel of the image at each of the 
illuminated wavelengths, as illustrated in Figure 10 [77, 127-130].  
Software is used to ensure the images are spatially aligned and can be properly 
analyzed. The relative absorbance spectra of tissue chromophores of interest (oxy- and 
deoxyhemoglobin, melanin, etc.) can be calculated by comparing the reflectance spectra 
to white references. Finally, absorbance information of oxyhemoglobin and 
deoxyhemoglobin are analyzed to create two-dimensional maps of oxygenation values 
(i.e., concentration of chromophores and oxygen saturation) over a wide spatial area on 
an anatomical map [127, 131]. The penetration depth of HSI is limited to several hundred 
microns beneath the surface of the skin due to the nature of reflectance-based modalities 
[132].  
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Figure 10: Concept of hyperspectral imaging: an entire spectrum is recorded at each pixel of the 
image providing a data cube. Reprinted from Reference [129]. 
Hyperspectral imaging has been applied to the evaluation of burn depth in animal 
[133] and human studies [134, 135]. In one study utilizing HSI, researchers observed an 
increase in levels of tissue oxygenation and hemoglobin content for superficial wounds 
compared to unburned healthy skin; while a decrease in these parameters was reported in 
full-thickness wounds [135]. The results from that study demonstrated HSI data could 
differentiate between first, second, and third degree burns. Figure 11 shows the 
hyperspectral image analysis of a patient with third degree burns compared to 
photographic images predicting deep-thickness skin loss. More recently, Calin et al. 
further demonstrated the utility of HSI for burn assessment by using HSI to identify 
subcutaneous edema more quickly than standard laser Doppler scanning techniques [134]. 
 
Figure 11: Photograph of patient with third degree burns (a) compared with hyperspectral image of 
the same patient (b) predicting deep-thickness skin loss. Reprinted from Reference [126]. 
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To the author’s knowledge, no studies on pressure ulcers have been conducted 
using HSI; however, the risk of ulceration or tissue damage has been assessed in other 
wound types before they were clinically apparent. One study used HSI to generate 
anatomical tissue oxygen maps that were predictive of the risk of ulceration in the 
diabetic foot prior to wound development [136]. HSI has also been shown to be predictive 
of the healing potential after diabetic ulceration has occurred [137] [130]. In a 2010 review, 
Yudovsky et al concluded that HSI can optimize therapies by monitoring the diabetic 
ulcer, predicting the ulceration risk, and predicting healing outcomes [138]. The use of HSI 
to provide information that can aid clinical assessment of ischemic wounds has also been 
demonstrated although it has not been widely applied [77, 139]. Noncontact reflectance 
spectrophotometric analysis has also been used to provide information on the depth of 
traumatic wounds; with hematomas near the surface having a different color impression 
than those in deeper tissue [140]. 
As with the above reviewed technologies, HSI has its limitations. The accuracy of 
hyperspectral imaging can be compromised if the interrogated surface is covered with a 
reflective fluid. When directly measuring wounds that have a reflective film layer on top, 
a significant loss of signal can occur due to a large portion of the incident light 
undergoing specular reflection. Specularly reflected light from the surface does not 
propagated through the wound tissue, and therefore does not contain information about 
wound composition. For this reason, some researchers have analyzed the intact skin 
immediately surrounding the wound rather than the center of the wound [130]. Another 
disadvantage of this modality includes its limited penetration depth [132] which render the 
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technology unfeasible for assessment of deep tissue injury in the absence of visual 
markers.  
3.7 Orthogonal Polarization Spectral Imaging 
Orthogonal polarization spectral imaging (OPSI) is a specialized form of in 
vivo transcutaneous videomicroscopy used to visualize microcirculation without the need 
for contrast agents. The schematic shown in Figure 12 demonstrates how an OPSI system 
works. Linearly polarized monochromatic light is used to illuminate skin tissue (via 
contact or an objective lens) and the backscattered depolarized photons are gathered 
through a secondary polarizer positioned orthogonal (perpendicular) to the plane of 
illuminating light [77, 141]. Single scattered photons, mainly coming from specular 
reflections at the tissue surface, will have the same polarization as the incident light and 
will be discarded by the second polarizer. Only photons that have experienced multiple 
scattering events within the sampled tissue and effectively lost their original polarization 
will be permitted through the polarizer and detected by a charged couple device (CCD) 
video camera. Subsequent analysis allows for the visualization of hemoglobin in the 
microcirculation [142] and quantification of the microvasculature by converting polarized 
light to optical density [77]. The resolution of OPSI systems is sufficient to image the 
movement of individual erythrocytes (red blood cells) traversing a capillary in real-time 
[141, 143]. The incident light source typically has a wavelength of 548 nm due to the equally 
high absorption of oxyhemoglobin and deoxyhemoglobin at this wavelength. 
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Figure 12: Schematic diagram of an OPSI system. Reprinted from Reference [144]. 
OPSI measurements have been used to assess skin microcirculation through the 
surface of the human burn wound. Groner et al. observed distinct patterns of circulation 
for healing and non-healing burn wounds using an OPSI device, as seen in Figure 13 [141]. 
In addition, Milner et al. utilized a non-invasive approach to image burn damage in vivo 
in 12 patients and establish a difference between the dermal microvasculature of 
superficial and deep burn wounds [143]. The authors reported superficial burns had small 
functional capillaries throughout the field of view, in contrast to the large coagulated 
vessels that were visible in deep burns. It is worth mentioning, however, that superficial 
burns and normal skin registered with the same optical density [143, 145]. OPSI has also 
been applied to the assessment of ischemic wounds [141] and provides information on 
microvasculature during cutaneous wound healing [146]. OPSI systems visualize the 
structure and function of dermal capillaries to determine an index of “functional capillary 
density” (FCD) which represents the length of perfused vessels in cm per cm2 of 
examined wound [61]. By setting the FCD threshold for deep partial thickness burns to 
100 cm/cm3, Goertz et al. were able to predict the need for operative intervention with a 
sensitivity of 93% [142]. The use of FCD, according to Kaiser et al., may provide a more 
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objective and reproducible measure of the capillary plexus than the relative grading 
system utilized in transcutaneous videomicroscopy [61]. Although FCD dramatically 
improves 1 to 4 days post-injury, an ideal measurement interval has not yet been 
established [142, 143].  
 
Figure 13: OPSI of (A) normal skin, showing the dermal capillary plexus as faint gray loops, (B) 
superficial burn, which looks similar to normal skin and (C) deep burn, in which the destruction of 
the overlying capillary plexus allows for visualization of the larger thrombosed dermal vessels 
beneath. Reprinted from Reference [141]. 
Orthogonal polarization spectral imaging is a relatively inexpensive, portable 
modality that is unaffected by skin curvature and does not require complete 
immobilization of the subject during measurement acquisition [142]. Nevertheless, there 
are a few potential limitations of using OPSI as a diagnostic tool of tissue damage in a 
clinical environment. Fields of view are small (~1 mm2) and only cover a small area 
during a single reading [61]; thus, thorough examinations can take up to 15 minutes to 
complete [142]. In addition, video examination is also time consuming and must be 
replayed and methodically reviewed to accurately assess burn depth [61]. Another 
potential issue involves the inability to image patients with high melanin content and 
edema. Virgini-Magalhaes et al. [147] indicated that patients with dark skin were excluded 
from their study due to limitations of the technique, while Goertz et al. [142] stated that 
20% of wounds in their study could not be accurately assessed due to the presence of 
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edema. Currently, OPSI technology does not offer an improvement over the clinically 
validated LDI devices for wound differentiation [77] and studies have reported it to be 5% 
less accurate compared to clinical assessment by experienced clinicians [142]. In its current 
state, OPSI modalities may be best suited for the research environment than the clinical 
field. 
3.8 Confocal Microscopy 
Confocal microscopy is another extension of the transcutaneous videomicroscopy 
technique. In its most basic form, it consists on focusing a light source onto a very small 
volume on a sample using mirrors and lenses [148]. First, a point light source becomes “P” 
polarized as it passes through a polarizing splitter; which contains a special mirror that 
transmits certain polarities and reflects light at 90-degree angles, as shown in Figure 14. 
This allows backscattered light from the sample to be differentiated from any other 
incident light that goes into the receiver. The transmitted light is then focused by a 
convex objective lens to a single point on the sample at a fixed focal distance (determined 
by the lens’ geometry) [148]. The backscattered light returns through the lens and back into 
the beam splitter. The splitter “S” polarizes the light and reflects it into an aperture 
(pinhole) designed to collect re-emitted signals originating only from the focal plane. In 
other words, the aperture selects for a specific focal depth by eliminating all out-of-focus 
photons backscattered from the surrounding areas. The remaining light carries 
information about the scanned point, creating a single pixel; thus scanning methods must 
be employed to create a large number of pixels over the entire sample [149].  
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Figure 14: Confocal microscopy schematic. Reprinted from Reference [150]. 
The most common scanning approach is to mechanically move either the sample 
or the light-source and detector in order to create an image (or optical section) of the 
entire surface. Multiple horizontally sectioned images can be obtained by adjusting the 
focal depth and are then stacked vertically in order to form a high resolution three-
dimensional map of the area of interest. The lateral resolution of measurements is 
determined by the size of the individual pixels, while the axial resolution of the image is 
controlled by how far apart the planes are scanned axially through the depth of the 
sample (maximum depth of ~350 μm) [151] [77].  
  Confocal microscopy exists in two similar but different modes, namely, confocal 
laser scanning microscopy (CLSM) and reflectance-mode confocal microscopy 
(RMCM). CLSM detects reflected light from tissue as described above and may be used 
to collect information at the cellular, morphological, and architectural levels of cutaneous 
wound repair [77]. By allowing visualization of inflammation, blood flow, and tissue 
formation, CLSM provides a non-invasive histological analysis over the course of wound 
healing and has been used to distinguish between normal and abnormal skin morphology, 
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as shown in Figure 15 [149]. However, it is limited to superficial wounds [152]. Reflectance-
mode confocal microscopy (RMCM) operates on similar principles to CLSM, by 
projecting a light source into the cutaneous tissue and provides high-resolution cellular-
level images [77]. Most commercially available confocal microscopes utilize NIR light 
sources [151] since light transmittance in cutaneous tissue increases with wavelengths in 
the NIR region (700–1,400 nm) [77]. RMCM allows for the simultaneous recording and 
evaluation of microcirculation, histomorphology and inflammatory cell trafficking, and 
has been used successfully for the study of burn wounds [153]. With this technique, dermal 
vessels appear like dark lines through which bright red blood cells can be visualized in 
real time [61]. The pigment of melanin adds contrast to the image and increases reflection, 
allowing rapid identification of the epidermal–dermal junction if still present post-burn 
[77]. RMCM is also able to visualize and quantify white blood cells, which proliferate 
considerably more in deep and deep partial wounds [154]. The ability to serially adjusting 
the depth of focus adds to the accuracy of wound depth determination and assessment of 
injury extent [61]. 
 
Figure 15: A) Photograph of superficial epidermal wound 7 days following cryosurgery with clear 
scab formation, b) photograph of wound closure 14 days post surgery, c) confocal laser scanning 
microscopy (CLSM) of wound 7 days following surgery showing wound closure and crust formation, 
d) CLSM showing wound is not completely restored. Reprinted from Reference [152]. 
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With advances in computer aided analysis, increasingly focused light sources, and 
improved scanning techniques, reflectance-mode confocal microscopy has become 
widely used for biological studies due to its high resolution and ability for three-
dimensional sectioning of a sample [155]. Nevertheless, this imaging technique is 
suboptimal for large fields of view since only miniscule fields (500 μm x 500 μm) are 
imaged; requiring repetitive measurements at multiple points to establish a representative 
sample of the wound [154]. This time consuming process is exacerbated by the lengthy 
review of the images needed after measurements which requires considerable expertise. 
In addition, interpretation can be difficult if optical sectioning is done in a plane parallel 
to the skin surface, as opposed to the more traditional perpendicular sectioning of 
biopsies [61]. Although it offers high resolution noninvasive “optical biopsies”, RMCM 
has not been extensively studied in human burn subjects and does not have absolute 
thresholds for differentiating superficial partial thickness from deep partial thickness 
burns (only relative temporal changes of blood flow and white cells) [154]. Additional 
studies that can indicate the accuracy, sensitivity, and specificity for this modality may 
increase its practical application in burn assessment; however, due to its limited 
penetration depth (~350 microns) clinical acceptance for pressure ulcer assessment is 
unlikely and would require further clinical trials. 
3.9 Spatial Frequency Domain Imaging (SFDI) 
Spatial frequency domain imaging (SFDI) is a recent noncontact wide-field imaging 
modality developed at the Beckman Laser Institute. SFDI is based on the same principles 
of diffuse optical spectroscopic as its predecessor, diffuse reflectance spectroscopy 
(DRS). DRS has been investigated within the context of burn wounds by multiple 
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research groups [133, 156, 157]. In DRS, polarized light at visible and near infrared (NIR) 
wavelengths is used to illuminate the tissue sample and the remitted cross-polarized light 
is captured with a camera or optical fiber to isolate features in the surface of the tissue. 
However, DRS has a limited penetration depth and is best suited for the assessment of 
superficial wounds [158]. 
 
Figure 16: Schematic of SFDI system. Reprinted from Reference [159]. 
SFDI is a new spectroscopy technique that involves the projection of sinusoidal 
patters of incoherent monochromatic NIR light onto cutaneous tissue and has the ability 
to specify particular depths of penetration, similar to the aperture of confocal microscopy 
[77]. The diffused backscattered light is then measured by a CCD camera to separate the 
absorption (μa) and reduced scattering (μs’) coefficients of the tissue under examination, 
as shown in Figure 16 [159]. By measuring wide-field surface optical properties at relevant 
wavelengths, the volume fraction of tissue chromophores like oxyhemoglobin, 
deoxyhemoglobin, and water are estimated (using a least square fit to Beer’s law) at 
different depths [160]. With the ability to interrogate skin depths of up to 5 mm, SFDI can 
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reproduce a three-dimensional map of both the perfusion and metabolic activity within 
the sampled area [159, 160]. 
Spatial frequency domain imaging has been applied to the interrogation of burn 
wounds. By quantifying changes in optical properties, SFDI has been reported to be 
capable of determining burn wound depth [160] and has been suggested to be able to 
identify wound infection [161]. Within the context of burns, the ability to measure changes 
in scattering has the potential to present information related to the changes in structure 
resulting from thermal denaturation (via scattering changes) and vascular damage [77]. 
Animal studies with SFDI have suggested the ability to determine tissue status in surgical 
flaps before, during, and after inducing vascular ischemia [162] as well as the potential to 
differentiate between superficial and deep wounds [158]. Nguyen et al. investigated the 
potential of SFDI to determine wound severity on a rat model as compared to histology. 
The study found that changes in water content (edema), hemoglobin concentration, and 
optical scattering could differentiate between superficial partial-thickness and deep-
partial thickness burns and correlated to hematoxylin and eosin (H&E) histology, as 
shown in Figure 17 [7]. 
 
Figure 17: SFDI oxygen saturation maps measured 3 hours after injury for a) superficial partial 
thickness burned rat, and b) deep partial thickness burned rat. Reprinted from Reference [160]. 
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 Ponticorvo et al. employed both SFDI and LSI as non-invasive technologies to 
characterize in-vivo burn severity in a Yorkshire pig model and correlated their findings 
to histological analysis [158]. The group observed differences in oxygen saturation (StO2) 
between full thickness burns when compared to superficial and deep partial thickness 
burns as soon as 24 hours post injury. However, no statistically significant differences 
between the StO2 of superficial partial thickness and deep partial thickness burns were 
reported. Parameters such as oxygenated and deoxygenated hemoglobin provided similar 
results. Furthermore, when looking at the reduced scattering coefficient (μs’), that group 
reported a decrease in μs’ for full thickness burns relative to the μs’ of normal skin as 
early as 1 hour after the burn, while partial thickness burns saw an increase in μs’. Unlike 
StO2 and hemoglobin content, a statistical difference was reported between the μs’ of 
superficial and deep partial thickness burns as early as 1 hour post burn. Overall, the 
results suggest changes in reduced scattering coefficient and blood flow could be used to 
categorize burn severity as soon as one hour after the burn injury [158]. 
The potential of SFDI to determine burn wound depth in humans and the 
identification of burn wound infection is promising, yet this modality is still very new to 
the field of cutaneous wound research. Although studies are underway, there is currently 
no clinical data to support the ability of this technology for burn or pressure ulcer 
assessment in human subjects. As this technology is still in its infancy, further 
investigation and extensive human studies will be needed to identify its clinical relevance 
and diagnostic potential.  
The relevant non-invasive optical technologies reviewed above have been 
previously used for either the assessment of burns or pressure ulcers with mixed success. 
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Many of these techniques have not yet been sufficiently refined for clinical application 
and none of them have yet to be thoroughly studied for the assessment of both burn and 
pressure ulcers in human studies. The diversity of the patient population with these 
wound types combined with the length of time required to properly complete human 
studies have limited the studies available or make definite conclusions from such studies 
difficult to reach. Additional studies are needed to fully explore the potential for 
incorporation of non-invasive imaging modalities into the routine treatment of wounds. 
As detailed above, a combination of factors varying from poor penetration depth, 
prolonged measurements times, and the difficulty of image interpretation (which could 
lead to misdiagnosis) have prevented the wide spread use of these technologies for 
pressure ulcer assessment and delayed their integration into the clinical environment.  
It is likely that perfusion and metabolic information combined with structural 
details of a wound will be critical to help clinicians properly identify the status of a 
suspected wound area and aid in the evaluation of new and / or existing wound 
treatments. The cost of wound care, in the form of nutritional supplements, active 
dressings, topical treatments, and overall management is significant and suboptimal 
classification of depth and wound type may result in unnecessarily invasive surgical 
treatment or treatment delays. Given this cost scenario, there is a need for diagnostic 
optical devices that can cost-effectively and non-invasively measure through the full 
thickness of human skin as well as subcutaneous tissues; providing critical information 
that can identify tissue damage at an early stage. Timely access to such information by 
clinicians has the potential to improve the quality of life of people who suffer from skin 
ulcers as well as help dampen the economic burden of healthcare by optimizing treatment 
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protocols and reducing length of hospital stay. Diffuse Correlation Spectroscopy when 
combined with Diffuse Near Infrared Spectroscopy meets all of these needs and therefore 
were the ideal systems to use for the research presented here. In the next chapter, the 
benefits of DNIRS and DCS modalities over the existing optical modalities will be 
discussed and an in-depth description of the systems will be provided. 
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CHAPTER 4: NEAR INFRARED SPECTROSCOPY 
Near infrared spectroscopy is a non-invasive and relatively inexpensive technique which 
can be used in a variety of settings by health care providers. In particular, Diffuse Near 
Infrared Spectroscopy (DNIRS) and Diffuse Correlation Spectroscopy (DCS) may 
provide a promising solution for the assessment of tissue damage by non-invasively 
measuring tissue oxygenation and blood flow. DNIRS can be used to non-invasively 
measure the optical absorption (μa) and reduced scattering (μs’) coefficients of tissue and 
oxyhemoglobin and deoxyhemoglobin concentrations at deeper depths of up to several 
millimeters (~1 cm), while DCS is able to provide information about the rate of capillary 
blood flow in the area of interest. The ability to measure through the full thickness of 
human skin as well as subcutaneous tissue, gives this combined optical method an 
advantage over superficial modalities. Furthermore, the cost of the opto-electronic 
components used to assemble these systems has decreased greatly in recent years, making 
the cost of our systems much less than other medical diagnostic systems such as LSI and 
MRI. 
Near infrared spectroscopy has been used successfully by our research team to 
quantify wound healing in chronic diabetic foot ulcers [163-167]. The findings over the past 
several years demonstrated that this non-invasive optical method of measuring 
hemoglobin oxygenation can predict whether a wound is likely to heal or remain open 
with 0.90 sensitivity and 0.86 specificity [16]. From these encouraging results we 
hypothesize that hemodynamic information from multiple depths may be used to 
determine the presence and extent of tissue damage on existing ulcers. In addition, as 
previously noted, there is considerable evidence linking blood vessel damage to 
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ulceration [24-26, 32-37] and it is likely that impaired tissue oxygenation and blood flow may 
serve as a useful indicator of tissue damage.  
 A brief background on the principles of operation for both Diffuse Near Infrared 
Spectroscopy and Diffuse Correlation Spectroscopy is presented below to gain a proper 
understanding of how these modalities function. The development and calibration 
procedures employed to successfully complete aim 1 (sub aims 1.1 and 1.2) are also 
detailed below. 
4.1 Diffuse Near Infrared Spectroscopy 
In turbid media, such as skin, light propagation can macroscopically be described as a 
diffusive process. DNIRS allows tissue to be non-invasively analyzed by measuring its 
optical absorption and reduced scattering coefficients (µa and µs’) using a number of 
equations derived by diffusion approximation. The reduced scattering coefficient is 
defined in terms of the scattering coefficient of tissue (µs) and the angular dependence of 
scattering (g) by the equation [µs’ = (1-g)∙µs]. The values of µa and µs represent the 
likelihood of an absorption or scattering event occurring in the probed tissue per unit 
length. More specifically, they represent on average the number of absorption/scattering 
events that occur within the probed media per unit length (measured in units of cm-1). 
These optical properties of tissue can provide information on the concentration of 
biologically important chromophores and composition of tissue structures [168]. In the red 
and near infrared spectrum of light, photons easily passes through biological tissue; 
allowing optical modalities to probe several centimeters into the tissue due to reduced 
absorption of light by water and strong absorption by hemoglobin [169, 170]. In this optical 
window, the main light absorbers in our region of interest are primarily oxygenated and 
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deoxygenated hemoglobin (HbO2 and Hb) [171]. An assessment of their concentrations can 
be achieved by measuring the attenuation and phase shift of intensity modulated light as 
it passes through tissue.  
DNIRS methodology can be implemented in three main experimental ways: Time 
domain (TRS), Frequency domain (FD), and Continuous wave (CW). For the purpose of 
this study, we will only focus on the frequency domain method since it enables us to 
accurately separate scattering and absorption information at a reasonable cost without 
compromising the ease of use [172]. Frequency-domain technique uses intensity modulated 
light at high frequencies (i.e., ≥ 70 MHz) infused into the tissue. The amplitude reduction 
and phase shift of the backscattered light are then measured at multiple distances. 
Absorption and reduced scattering coefficients can be calculated by comparing the 
measured phase and amplitude (∆𝝋 and Aatt) data to analytically derived model functions 
[173]. The model functions were derived by Haskell et al [174] from solutions of the photon 
diffusion equation which yield expressions for amplitude and phase as a function of 
modulation frequency (ω), μa, and μs’.  
4.1.1 Theoretical Background 
Conventionally, optical fibers are used to carry the light to and from the tissue. A probe is 
often used to fix individual fibers in place in a configuration which yields multiple 
distances between light source and detector fibers with all distances being greater than 
the transport length. The transport length l’ represents the distance a collimated beam of 
light travels before it becomes effectively isotropic (loses directionality). Below this 
distance, the propagation of the laser light would still be highly directional and thus not 
able to be accurately described by the diffusion approximation. By measuring beyond the 
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transport length, it can be assumed that the motion of the particles is effectively 
randomized and the propagation of the light may be described by a diffusion model [175, 
176]. Thus, in order to assure the incident light has diffused properly, a minimum distance 
between source and detector fibers (ρ) greater than three transport lengths is often used. 
After propagating more than two or three transport lengths, most photons undergo 
multiple light scattering events and can be considered diffuse [175, 176]. For human tissues, 
the optical scattering (µs) is ~10 cm-1. Since, l’ is the inverse of the reduced scattering 
coefficient (µs’), the transport length l’ for human tissue is approximately 1 mm. This 
indicates that the smallest ρ that could be used in a probe design is 3 mm, in order for the 
diffusion approximation to be valid [177]. The depth of penetration of light into tissue is 
also dependent on ρ. An acceptable approximation for the depth penetration in tissue is 
between one third to half of the source-detector distance (ρ) [178, 179]. Knowing the 
absorption spectrum of each chromophore, it is possible to calculate its concentration 
using the Beer-Lambert equation below for each wavelength (λ) of incident light [180]:  
                                         𝝁𝒂(𝛌) = ∑ 𝛆𝐢(𝛌) ∗ 𝐜𝐢𝐧𝐢                                  (1) 
where )(λε i  is the wavelength-dependent extinction coefficient of the i-th chromophore, 
ci is the concentration of the i-th chromophore, and n is the total number of different 
chromophores in the medium. For this project, the main chromophores of interest are 
oxygenated hemoglobin and deoxygenated hemoglobin. The amount of lipid absorption 
within pressure ulcers and burns could be assumed to be negligible while the percentage 
of water in the measured tissue will be assumed to be 70% [169, 170]. Thus, the below 
equation can be used to describe the relationship between measured values of absorption 
coefficient (µa) and the concentrations of hemoglobin and water [181, 182]. The absorption 
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measured at each individual wavelength is attributed to the primary chromophore at that 
wavelength, utilizing the molar extinction coefficients defined in [180]: 
                     [ ] [ ] [ ] µµεε
λλλλ
measuredaOHaHBOHb
OHHbOHb
,22,22
% =++    (2) 
where λ = 685 nm, 830 nm,  and  are the molar extinction coefficients of 
deoxygenated and oxygenated hemoglobin as published in Prahl 1999 [163], µa,H2O is the 
absorption coefficient of pure water as published in Hale and Querry in 1973 [164], and [% 
H2O] is the percentage of water in the measured tissue. Values of [HbO2] and [Hb] can be 
derived from the experimental values of µa measured through a simple system of equations. 
Thus, a minimum of two wavelengths of incident light are needed for calculation of 
[HbO2] and [Hb]. Total hemoglobin concentration is calculated by adding the calculated 
concentrations of oxygenated and deoxygenated hemoglobin, while oxygen saturation is 
obtained as a ratio of oxygenated hemoglobin to total hemoglobin concentrations. 
The equations for amplitude and phase shift of intensity modulated light from 
which the optical properties could be derived are given below. The below equations 
assume light is propagating in a macroscopically homogeneous medium (such as skin) 
using semi-infinite boundary conditions (such as the ones expected at a probe-skin 
boundary) [174]: 
  
  (3) 
    
                                          (4) 
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λ
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Aatt and φ represent the amplitude attenuation and phase shift of the incident modulated 
light respectively. D is the diffusion coefficient and is defined as D =1/[3 ∗ (µa +  µs′)]. 
Air is the net amplitude response of the instrument (i.e., source power) and Reff is the 
effective reflection coefficient which represents the fraction of light that has reached the 
surface and is reflected back into the tissue due to the index of refraction mismatch at the 
medium boundary. Haskel et al. defines Reff as 0.493 for typical values of air-tissue 
interfaces (based on nair = 1 and ntissue = 1.40). Nair and Ntissue represent the refraction 
index of air and tissue respectively [174]. The source-detector separation on the surface of 
the turbid medium is defined by ρ. The speed of light in the medium is given by c 
((3.0x1011 mm/s)/1.40 for tissue) [36]. Zb is the distance from the turbid medium surface 
(tissue surface) to an extrapolated boundary condition outside the turbid medium. It is 
called the linear extrapolation distance and represents a distance away from the tissue 
where the fluence is assumed to vanish in order for the model equations to become 
simplified. Kreal and kimag are the real and imaginary parts of the diffusion wavenumber. 
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As the modulation frequencies (ω), source detector separation, measured amplitude, and 
phase shift are all known, the values of µs’ and µa in tissue can be calculated [183]. Phase 
or amplitude data alone provide sufficient information to extract the absorption and 
reduce scattering coefficients. However, previous studies have shown that the use of both 
data simultaneously can significantly improve the robustness and fidelity of the fit [36].  
A sweep of modulation frequencies over a single distance or the use of a single 
frequency over multiple source-detector separations can be used for the calculation of 
optical properties. If a multiple distance approach is used, the simplified linear 
relationships shown below can be used to approximate the desired optical parameters of 
optical absorption and reduced optical scattering [184],  
                  𝒍𝒏[𝝆𝟐 ∗ 𝑨𝒂𝒕𝒕(𝝆)] = −𝒌𝒓𝒆𝒂𝒍 ∗ 𝝆 + 𝐥𝐧 (𝑨𝒊𝒓)                            (12) 
                                            𝛗(𝝆) = 𝒌𝒊𝒎𝒂𝒈 ∗ 𝝆 + 𝛗𝟎                                     (13) 
where kreal and kimag represent the slopes of the linear relationships and could be 
extracted from measured amplitude (𝑨𝒂𝒕𝒕) and phase shift (φ) data by plotting the phase 
shift and logarithm (base 10) of the detected amplitude times the square of the distance vs 
source detector separation. The values of µs’ and µa are then altered until the combination 
which provides the best fit of the slopes is achieved. Finally, using the spectra of 
hemoglobin as previously shown, physiological information is extracted. 
Frequency domain DNIRS can be used to quantify oxygenation in tissue. Since 
metabolic changes of oxygen consumption take time (up to several minutes) to occur and 
be detected, a dynamic method that can quickly detect changes in blood flow may prove 
beneficial for the fast assessment of tissue viability. Continuous wave (CW) methods 
such as Diffuse Correlation Spectroscopy can be used to obtain information regarding the 
dynamics of red blood cells [172] by monitoring speckle fluctuations of the scattered light. 
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These changes in speckle pattern have been previously used to understand hemodynamic 
changes in tissue in several fields of science [76, 185, 186]. The ability of diffuse correlation 
spectroscopy to probe microvasculature at depths beyond 1 mm and assess flow in real 
time will be further explained on section 4.2 of this chapter.  
4.1.2 System Design 
The first step towards the characterization of tissue damage begins with the construction 
and testing of a Diffuse Near Infrared Spectroscopy (DNIRS) device able to probe at 
multiple tissue volumes. The device was ultimately combined with a Diffuse Correlation 
Spectroscopy system. 
Hardware 
The proposed DNIRS system consists of two separate parts: (1) a “module assembly” 
containing the opto-electronic components such as lasers, photodetectors, and RF 
generators, and (2) an optical probe. The optical probe can have three different 
configurations: Non-contact, semi-contact, and fully contact. Each configuration has its 
own advantages and requires slightly different hardware from the rest. A non-contact 
system is ideal for assessing open wounds such as burns since it reduces the risk of 
infection during measurements, while a contact system provides faster measurements, 
easy set up, and can easily be used in a clinical setting for the assessment of intact-skin 
pressure ulcers. A description of our overall system will be given and differences in 
hardware and functionally between the different configurations will be described 
whenever relevant.  
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Module Assembly 
The “module assembly” containing opto-electronic parts has been assembled within a 
standard 12” rack with 6 shielded NIM box modules (Nuclear Instrumentation Module). 
The contents of each module are: 1. Power supply, 2. Radio Frequency (RF) Generator 
(50-400 MHz) with variable gain amplifier, 3. Laser diodes (685 nm and 830 nm) with 
drivers, 4. Optical switch and stepper motor driver, 5. Photodetectors with amplifiers and 
IQ demodulators. A National Instruments USB-6251 M Series DAQ Card is used for data 
acquisition and digital control of several components. A personal computer equipped 
with LabVIEW® and MATLAB® software provides the control interface for the overall 
system and analysis/fitting of experimental data to calculate the optical properties and 
hemoglobin concentrations within tissue. A high level block diagram of the DNIRS 
system showing the inter-connections between the different modules in a non-contact 
configuration is shown in Figure 18. 
 
Figure 18: High level block diagram of DNIRS system for the non-contact configuration representing 
the main components within the different modules. 
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 Different system components require different levels of voltage in order to 
operate. The power supply module converts the alternating current (AC) coming from the 
wall outlet into direct current (DC) that can be used to power the different components of 
our device. This module provides voltages at 3.3, 5, 12, and 15 V. Inside of the RF 
module, a locking programmable sine wave generator (Novatech Instruments, LPO400A) 
produces sinusoidal Radio Frequency (RF) signals ranging from 50 to 400 MHz with a 
1MHz step resolution. One channel, called the local oscillator (LO), is kept as a 
reference. The second RF signal modulates the intensity of light emitted from the laser 
diodes. As the modulation frequency changes from 50 to 400 MHz, the response of our 
electrical components varies slightly, causing inconsistent modulation depths of laser 
radiation across different frequencies. To compensate for this difference, a variable gain 
amplifier (Analog Devices, AD8375) is used to maintain a constant modulation depth of 
laser radiation. The AD8375 variable amplifier can modify the amount of RF signal 
attenuation from 0 to 24 dB (with 0 decibels representing the highest gain and 24 decibels 
representing no gain). Both the RF generator and variable gain amplifier are controlled 
via the acquisition board and laptop computer.  
The RF signal coming from the variable amplifier modulates the intensity of the 
semiconductor laser diodes. In-house built laser drivers are used to mix the DC bias of 
our laser diodes with the AC signal from our RF generator in order to obtain intensity 
modulated light. In addition, the drivers protect the laser diodes from excessive current 
damage. The design of the driver depends on the laser type and may use an integrated 
circuit from Sharp Corp. or from iC-Haus GmbH as well as a bias-tee from Mini-
circuits©. A 4 x 1 optical switch (DiCon Fiberoptics) allows to cycle between the two 
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laser diodes and an offset (no light) position for each individual distance/frequency. The 
offset value is used to determine (and compensate for) the dark current of the system, 
which refers to the voltage read by the device when no incident light is being delivered. 
A variable optical attenuator (Oz Optics, Ltd) is connected in between each laser diode 
output and the corresponding optical switch inputs to provide control over the intensity of 
light delivered to the tissue.  
Light is delivered to and from the tissue via optical fibers or a lens assembly, 
depending on the type of optical probe being used as illustrated under the Optical Probe 
Assembly section. The backscattered light is collected by a detector fiber directly 
touching the optical system being probed or which has been aligned at the focal point of a 
relay lens and transports it into a photodetector. The electrical signal from the 
photodetector(s) is passed through two fixed amplifiers (Mini-Circuits, ZFL-500LN and 
Mini-Circuits, ZFL-500HLN). Then the signal is fed to an In-Phase/Quadrature (I/Q) 
demodulator (MERRIMAC IQM-9B-500), which compares the detected signal to the 
reference LO signal from the RF generator. The outputs of the I/Q demodulators are the 
cosine (I) and sine (Q) low frequency components of amplitude and phase shift relative to 
the reference signal. The I and Q signals are then passed through a low-pass filter (DC to 
1.9 MHz) and digitized by the data acquisition board prior to being recorded and 
displayed on a laptop computer. A detailed block diagram of the system in a contact 
configuration highlighting the flow of operation is shown on Figure 19.  
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Figure 19: Detailed schematic of frequency-domain near infrared system for contact configuration. 
In this configuration, 2 APD detectors with their corresponding IQ Demodulators are used to 
increase the number of source-detector separations along with a 2x8 optical switch. 
Optical Probe Assembly 
The optical probe assembly can be adjusted into three different configurations: (1) Non-
contact, (2) semi-contact, and (3) fully contact. Figure 20 shows the available set ups for 
the optical probe. 
  
                    (A)                                           (B)                                                    (C) 
Figure 20: Non-contact (A), semi-contact (B), and fully contact (C) optical probe set ups available for 
our DNIRS system. 
In the non-contact configuration, a lens assembly first collimates and then focuses 
the laser light from the source fiber onto the skin at a location controlled by the digital 
actuator. The digital actuator changes the source-detector separation from 2 mm to 2 cm 
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via a stepper motor driver controlled by the data acquisition board with a step size of 
0.25mm. The backscattered light is collected by a relay lens (Edmund Optics, M45-762) 
and focused onto a 62.5/125 μm multimode detector fiber which delivers the light to a 
photodetector as shown in Figure 20A. In the semi-contact configuration (Figure 20B), 
instead of using a relay lens to collect the backscattered light, a detector fiber is in direct 
contact with the tissue. Finally, in the fully contact configuration no lenses or digital 
actuators are used. Instead optical fibers fixed within a thermoplastic (ABS) probe deliver 
the light to and from the tissue. The incident laser light is delivered to the system by eight 
62.5/125 μm multimode optical source fiber, while two optical fiber bundles with 1.0 mm 
diameters are used to deliver backscattered light to two avalanche photodiode (APD) 
modules (Hamamatsu C5658). APD modules were used due to their wide range of 
operating frequencies (up to 1000 MHz) which allow full usage of the RF generator’s 
range of frequencies. The broad linear range of an APD combined with its ability to 
detect high levels of incident light without being damaged made it an ideal detection 
system for the applications of this research. The contact configuration provided a total of 
16 source-detector separations ranging from 4 mm to 19 mm. A 2x8 optical switch 
(DiCon Fiberoptics) enabled the delivery of modulated laser light to each of the source 
fibers by cycling through each laser and source fiber combination. Figure 20C illustrates 
a contact set-up using only a single detector fiber for ease of understanding. 
The non-contact and semi-contact configurations allow for minimal to no contact 
with the tissue being assessed which is useful to minimize pain and risk of infection 
during measurements. As previously described, both configurations use a fixed detector 
fiber and a lens coupled source fiber mounted on a stepper motor to carry light to/from 
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the optical system being assessed (i.e. damaged tissue). While these set ups allow for 
virtually unlimited number of source-detector separations, the use of lenses make them 
highly susceptible to motion artifacts and difficult to use in a clinical setting. A fully 
contact system allows for a finite number of source detector separations but is less 
sensitive to motion artifacts and can be easily integrated into a clinical environment.  
A modified contact probe was also developed in order to obtain optical 
measurements under load-bearing conditions. This probe was specifically designed to 
obtain measurements of intact sacral skin from patients at high risk of pressure ulceration. 
Further details on the development and composition of this probe are provided in section 
4.2.2 after the description of the DCS system. Figure 21 shows a diagram of the probe.  
 
Figure 21: Schematic of modified contact probe, consisting of optical fibers glued to right-angle 
prisms, enclosed by a protective metal cylinder, all embedded within a silicone pad. The dashed red 
line represents the path of light through the probe. 
Software 
Upon completion of the hardware development, LabVIEW® software was developed to 
function as the user interface, data collection, and controlling mechanism for our DNIRS 
system. A Graphical User Interface (GUI) was designed and implemented. The software 
enabled real-time visualization of amplitudes and phase shifts measured by the DNIRS 
system. During the data acquisition process, the DNIRS data was used as inputs to the 
calculation of optical absorption and reduced scattering coefficients. Optical absorption 
coefficients were used to calculate the concentration of oxyhemoglobin, 
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deoxyhemoglobin, total hemoglobin, and oxygen saturation. All measured and calculated 
data elements were exported to text files. The software program allowed to dynamically 
change the modulation frequency, amplification of RF generated signal, optical switch 
output channel, as well as the source-detector separation and actuator step size (when not 
using a contact approach) through a laboratory laptop computer. MATLAB® program 
was used for data analysis. The testing and calibration of the DNIRS system will be 
presented next. 
4.1.3 Calibration and Testing 
Linearity Range 
Prior to in-vitro or in-vivo experiments, a calibration procedure was conducted to define 
the range of linearity of our photodetector(s). As with any optical detector, the Avalanche 
Photodiode (APD) module has a limited range where the electrical output signal is 
linearly proportional to the optical power of the incident light. A two way optical splitter 
was used to re-direct equal amounts of laser light (685 nm) into our photodetector and an 
optical power meter. The intensity of detected light was compared to measurements from 
the optical power meter. The relationship between the detected amplitude/phase shift and 
the incident optical power is presented in Figure 22.  
The linearity test was performed at a modulation frequency of 80 MHz. The 
observed linear range for our photodetector expands from 1 to 180mV. The regression 
slope of 0.98 shows a positive correlation and indicates a linear relationship between 
detected intensity and incident optical power. Similarly the regression slope for phase 
shift was essentially zero indicating a non-linear relationship between phase shift and 
60 
 
   
intensity of incident light at the same source-detector separation. The standard deviation 
of phase shift values was 0.03 radians or 2 degrees.  
 
Figure 22: Plots of amplitude vs. power and phase shift vs. power. The plots indicate amplitudes 
within 1mV-180mV are within the linear range of the detector. 
Any subsequent measurements that fell outside of the range of linearity were 
discarded and retaken after adjusting the amplitude of the signal using optical attenuators. 
A series of in-vitro tests were then performed to validate the efficacy of the device and 
evaluate the consistency and repeatability of measurements. 
Titration and Ink Experiments 
Suspensions of Intralipid and India ink with known absorption and reduced scattering 
coefficients were used as optical phantoms to assess device accuracy. The Intralipid used 
in the experiments (Liposyn 20% from Abbott Laboratories) was diluted in deionized 
water to concentrations ranging from 0.5-2.0% to produce liquid phantoms with reduced 
scattering coefficients (µs’) similar to those in human tissue. A titration experiment was 
conducted where the above mentioned dilutions of Intralipid solution were measured. As 
the concentration of Intralipid decreases, so does the number of scattering molecules, thus 
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a decrease of µs′  was observed for lower Intralipid concentrations. Conversely, the 
number of absorber molecules is not affected by the dilutions, thus µa was expected to 
remain fairly constant. Figure 23 shows the results of the titration experiment with the 
different Intralipid dilutions. 
 
Figure 23: Titration experiment with four different concentrations of Intralipid solution. μs' 
increases as Intralipid concentration increases, while μa stays relatively unchanged. Measurements 
were taken at a modulation frequency of 100 MHz using 685 nm light. 
An ink experiment was also performed where diluted Black India Ink (Higgins 
Corp) was added in 1 mL increments to 1 liter of 1% Intralipid solution to resemble the 
range of optical properties found in human tissue based on skin tone and tissue 
composition. As the concentration of ink solution increases, so does the number of 
absorbing molecules, thus an increase in µa was observed. Conversely, the number of 
scattering molecules is not affected by the addition of the ink solution and µs′  was 
observed to remain fairly constant. Figure 24 shows the results of the ink experiment. 
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Figure 24: Change in μa and μs’ during India ink experiment. The μa increases as ink concentration 
increases, while μs' stays relatively unchanged. Multiple modulation frequencies were tested to assure 
repeatability of results across all possible frequencies. 
Stability 
The use of Intralipid phantoms for experiments that may last multiple hours is not 
optimal because the solution changes optical properties due to degradation and phase 
separation (aggregation). Single layer solid phantoms can overcome some of these 
challenges since their optical properties do not change over the time span of our 
experiments. Consequently, the ability for the instrument to provide consistent readings 
throughout measurement sessions lasting up to 1 hour was validated using silicon 
phantoms. Solid silicon phantoms were formulated for stability testing using dispersed 
particles of titanium dioxide (TiO2) and carbon black to mimic the properties of human 
tissue. A masterbatch containing 5grams of carbon black, 0.25 grams of TiO2, and 105 
grams of uncured silicon base was thoroughly mixed for 1 hour. 10.5 grams of silicon 
activator were added and mixed until the mixture appeared homogeneous. A vacuum 
desiccator was used for 45 minutes to remove the air trapped in the silicon during mixing. 
Finally the mixture was removed from the vacuum and left to cure for 24 hours. Stability 
measurements were obtained at a single source-detector separation over a period of 1 
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hour using a modulation frequency of 160 MHz. Device stability over 1 hour period 
showed consistent readings for both amplitude and phase. The standard deviation for 
amplitude and phase shift was 0.9% and 0.003 radians (0.2 degrees) respectively as 
shown in Figure 25.  
 
Figure 25: Amplitude and phase readings during one hour stability test using a silicon phantom. 
In order to assure consistent and stable results were obtained from day to day, 
routine measurements were taken on a solid silicon phantom using a multi-distance 
approach. The day by day stability test is shown in Figure 26.  
 
Figure 26: Stability of absorption and reduced scattering coefficients from day to day for a solid 
phantom during a period of 6 days (< 3% deviation). 
The optical properties of silicon phantoms were also measured using multiple 
source-detector separations at different modulation frequencies. The obtained optical 
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properties fall within the expected values for our in-house solid silicon phantom 
(obtained values µa = 0.056 and µs′  = 13, expected values µa = 0.06 and µs′  = 14) as 
shown in Figure 27.  
 
Figure 27: Absorption (right) and reduced scattering (left) coefficients obtained for multiple 
modulation frequencies using a multi-distance approach. The standard deviation across the different 
frequencies for the optical properties is ~ 9% (standard error < 3%). 
4.2 Diffuse Correlation Spectroscopy (DCS) 
Diffuse Correlation Spectroscopy (DCS) is an optical modality which analyzes the 
temporal autocorrelation function of scattered light as it is transmitted through tissue. 
Mathematically, the autocorrelation function represents fluctuations in the reflective 
index and connects the scattering intensity of a particle at a specific point in time t, with 
its scattering intensity at a later time (t + τ) when the particle would have moved in the 
coordinate system. This dynamic method essentially monitors the speckle fluctuations of 
the scattered light, which in turn are sensitive to the motions of scatterers such as red 
blood cells [172]. Dynamic light scattering or photon correlation spectroscopy has been 
previously used to study molecular motions in solutions, biopolymers, and liquid crystals 
among others [187-189]. Since then, this technology has been successfully implemented in 
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multiple animal [190-193] and human studies [194-197]. This sub section provides a brief 
theoretical background in DCS and a detailed description of our optical system. 
4.2.1 Theoretical Background 
The primary approach for calculating flow via DCS involves measuring the electrical 
field temporal autocorrelation function (G1), which represents fluctuations in the 
refractive index of the sample being probed and is directly related to the movement of 
scatterers (i.e. red blood cells moving within the tissue volume probed). Since the 
electrical field temporal autocorrelation function for light traveling in highly scattering 
media (such as skin) also obeys a diffusion equation [198, 199], the same general analyses 
applied in the case of photon fluence rate is valid for photon correlation. The layout of 
the sources and detectors is similar to the DNIRS design, but the correlation 
measurements are different. Sources and detectors are placed on the surface of the tissue. 
The photons undergo scattering, absorption and experience Doppler shifts when they 
scatter from moving particles. The motion of the scatterers leads to fluctuations in 
intensity which are detected by single photon counting detectors. The temporal 
autocorrelation functions of the intensity are then calculated using an autocorrelator. The 
autocorrelator takes the output from the detectors and uses the photon arrival times to 
compute the temporal autocorrelation function of scattered light intensity, represented by 
[198]: 
                    𝒈𝒔(𝝉) = 〈𝑰(𝒕)∗𝑰(𝒕+𝝉)〉〈𝑰𝟐〉                                                  (14) 
where (I) is the registered light intensity at time t, τ is the delay time of the 
autocorrelator, and < > is used to denote averaging, which is performed throughout the 
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entire acquisition time. A complete description of how the autocorrelator operates can be 
found in Reference [200].  
In a multiple scattering regime that is relevant to medical applications, the 
diffusion equation for a continuous wave (un-modulated) light source has been solved for 
semi-infinite geometry [22,35-37]. The expression for the field autocorrelation function [201] 
is dependent on µs’ and µa, and is represented by  
 𝑮𝟏(𝝆, 𝝉) = 𝟑µ𝒔′𝟒𝝅 �𝒆−𝒌𝑫𝒓𝟏𝒓𝟏 − 𝒆−𝒌𝑫𝒓𝟐𝒓𝟐 �;                                   (15) where: 𝑟1 = �𝜌2 + (𝑧 − 𝑧0)2  , 𝑟2 = �𝜌2 + (𝑧 + 𝑧0 + 2𝑧𝑏)2 ,  𝑘𝐷 =
�3𝜇𝑎𝜇𝑠′ 2 + 6𝜇𝑠′2𝑘02𝛤𝜏, ρ is the source-detector separation distance, z is the vertical 
distance from the source to the tissue (z = 0 cm for contact system), 𝒛𝟎 = 1 ⁄ (µs′) 
represents the distance between the imaging source and the imagined negative isotropic 
source 𝒛𝒃 given by 
    𝒛𝒃= −
𝟐
𝟑𝝁𝒔
′
𝟏+𝑹𝒆𝒇𝒇
𝟏−𝑹𝒆𝒇𝒇
;                                                     (16) 
𝑹𝒆𝒇𝒇 is the effective reflection coefficient, ko is the photon wave number (2π/λ), and 
𝐺1(𝜌, 𝜏) can be determined using the Siegert relation 
  𝑮𝟐(𝝆, 𝝉) = 𝟏 + 𝜷[𝑮𝟏(𝝆, 𝝉)]𝟐,                                        (17) 
where β depends on the detection optics of the system. For in-vivo DCS measurements, 
where the predominant moving particles in the tissue are red blood cells, the effective 
tissue blood flow can be characterized by using the diffusion coefficient 𝑫𝑩 and the 
Blood Flow Index (BFI) defined as 𝜶𝑫𝑩 where α is proportional to the volume of red 
blood cells in the tissue, which is assumed to be 0.01[200]. A complete description of the 
governing equations was given by Li [202].  
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4.2.2 Optical System 
Hardware 
Diffuse Correlation Spectroscopy (DCS) was used to measure microcirculatory blood 
flow at depths of approximately 3-6 mm in potentially damaged tissue. Our experimental 
instrumentation included a multimode optical fiber that transports light (wavelength 785 
nm) from a long-coherence length (~10 m) laser (CrystaLaser, Reno, NV) to the tissue. 
Two separate single mode fibers (core diameter ~5 µm) transported light from the tissue 
to a single photon counting module (SPCM) (Pacer, Palm Beach Gardens, FL). The 4 
channel SPCM component could register 2 million photon counts per second per channel 
and can detect the arrival of a single photon with an accuracy of ~350 ps. The electrical 
impulses (30 ns wide TTL pulses) corresponding to the counted photons were 
discriminated and amplified in the built-in circuits of the detector. The digital output of 
the SPCM was connected to a multi-tau autocorrelator (Correlator.com, Shenzhen, 
China) which converted the photon arrival times into the temporal autocorrelation 
function of scattered light intensity used to calculate the diffusion coefficient 𝑫𝑩 via 
diffusion approximation as described above. At each measurement time point, the DCS 
device collected a single 𝑫𝑩 value with an averaging time of 1.5 seconds. Figure 28 
shows a block diagram of the DCS system. 
There are two methods to obtain values of 𝑫𝑩 from fittings of experimental data. 
The first method involves the use of fixed values of typical tissue optical properties; the 
second involves measurements of optical properties as DCS measurements are 
simultaneously taken from the same tissue volume using the Diffuse Near-infrared 
Spectroscopy (DNIRS) system. The simultaneously obtained µa and  µs′  can be used for 
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the determination of absolute values of 𝑫𝑩 [200] within the probed tissue while 
calculations using constant values of µa and  µs′  (0.1 cm-1 and 10 cm-1 respectively) would 
yield relative values.  
 
Figure 28: Sample schematic of the DCS system layout during measurements. Reprinted from [203]. 
As mentioned earlier, an optical probe was developed in order to obtain 
measurements under the weight of a research subject. The probe immobilized the optical 
fibers that transport light from/to the DCS/DNIRS components and tissue by integrating 
them into a 3D-printed acrylonitrile butadiene styrene (ABS) core that was embedded 
within a thin silicone pad. Ninety degree optical prisms (side 2mm) were fixed to the 
ferrule tip of each fiber using optical adhesive. The prisms allow the delivery of laser 
light into the patient’s tissue by redirecting it from a horizontal into a vertical direction. 
The light transmission of the prism fibers was approximately 90% of the transmission 
from the same fibers without prisms.  
Software 
LabVIEW® software was developed for the DCS device and integrated with the DNIRS 
code into a single program prior to clinical studies. The software enabled real-time 
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visualization of the autocorrelation function as a function of time delay (τ) from the DCS 
detector on a monitor as data was acquired. During the data acquisition process, DNIRS 
data were used as inputs (along with the correlation function data) to the calculation of 
the blood flow index (α𝑫𝑩). All data elements were exported to text files and analyzed 
via MATLAB®.  
4.2.3 Calibration Procedures 
The three main components of the DCS system (long-coherence laser, SPCM, and 
autocorrelator) are all commercially available and come with their own sets of validations 
and pre-calibrations. In addition, the DCS system has been previously validated in 
multiple publications [193, 196, 204, 205]. However, the system was further calibrated to ensure 
the newly constructed device was operating properly and produced reproducible results. 
Initial calibration and testing of the DCS system used for this research were previously 
completed by a member of our research team (Dr. Joshua Samuels) as part of the 
requirements for his doctorate degree and can be found in Reference [203]. A brief 
summary of the in vitro testing and calibration procedures employed by the research team 
will be presented next for both the single and multiple scattering regimes. 
Single scattering correlation spectroscopy 
Monodisperse suspensions of polystyrene microspheres (Polysciences Inc., Warrington, 
PA) with diameters of 202 nm, 350 nm, or 500 nm were diluted to a concentration of 7.5 
parts per million. Suspensions were placed in transparent cuvettes, and the DCS source 
and detector fibers were placed at 90 degree angles to each other on the outside of the 
cuvettes. Ten scans of 10 seconds each were performed for each microsphere suspension. 
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To calculate the diffusion coefficient (𝑫𝑩), the measured temporal correlation functions 
of scattered light intensity were fitted to the equation 
          𝐺2(𝜏) = 1 + 𝑒−2𝐷𝑏𝑞2𝜏,                                     (18) 
where,  
  𝑞 = 4𝜋𝑛0sin (𝜃/2)
𝜆
,                                          (19) 
 𝒏𝟎 is the index of refraction (1.33), λ is the wavelength of the laser (785 nm), and θ is 
the angle of scattering (90o). The size of the particles can be determined from 𝑫𝑩 using 
the Stokes-Einstein equation: 𝑟 = (𝑘𝐵 𝑇) ⁄ (6𝜋𝜂𝐷𝐵), where 𝒌𝑩 is the Boltzmann 
constant, T is the temperature, η is the viscosity of water, and 𝒓 is the diameter of the 
sphere. The computed sizes were statistically similar (p > 0.05) to the sizes calculated by 
a commercial particle size analyzer (Zetasizer Nano ZS, Malvern, Westborough, MA), 
which operates using the same principle of dynamic light scattering.  
Multiple Scattering Correlation Spectroscopy 
To create a multiple scattering environment, a 1% solution of Intralipid was measured 
with source and detector fibers placed on the surface of the liquid. This concentration of 
Intralipid corresponded to typical optical properties of living tissue (µs′  ~ 10𝑐𝑚−1 )[206]. 
The diffusion coefficients were calculated using source-detector separation distances 
ranging from 10-25 mm. The autocorrelation function plots are shown in Figure 29. 
Increasing source-detector separation distances manifested as shifts in the autocorrelation 
function to the left (to smaller times), representative of the increasing number of 
scattering events. The average diffusion coefficient was 8.1 x10-9 cm2/s with a 3% 
standard deviation for all 3 distances.  
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Figure 29: Autocorrelation functions for different source detector separations in multi scattering 
regime (1% Intralipid). 
A flow phantom with embedded optically-transparent rubber tubing (1.5 mm 
inner diameter) in a coil shape within a silicone phantom at 3-4 mm below the phantom 
surface had been previously used to determine the linearity of the system. The phantoms 
were constructed from room temperature vulcanizing (RTV) silicone (XP-565, Silicones, 
Inc.) mixed with titanium dioxide particles (0.9 - 1.6 μm, Alfa Aesar) to scatter light and 
carbon black particles (50% compressed, 99.9+% metals basis, diameter = 0.042 μm, 
Alfa Aesar) to absorb light. A controlled flow of 0.4% Intralipid solution was pumped 
through the tubing using an automated syringe pump (KDS220, KD Scientific, Holliston, 
MA) at speeds ranging from 0.5-4 mL/min. The diffusion coefficients were plotted 
against the flow rates to determine the linearity of the system, resulting in a coefficient of 
determination (R2) of 1.00. 
Cuff Experiments 
The ability of the system to identify changes in blood flow was tested in order to ensure 
proper functioning prior to the start of clinical studies. Pressure cuff experiments were 
conducted using a sphygmomanometer placed on the left upper arm of a healthy 
individual with continuous measurements taken on the forearm prior, during, and after 
72 
 
   
applying pressure. Baseline measurements (prior to applying pressure) where taken for 
approximately 1 minute. Then, the pressure cuff was inflated and held at a constant 
pressure of 200 mmHg for approximately 4 minutes. Finally, the pressure was quickly 
released and measurements were taken for 2 additional minutes. Figure 30 shows the 
calculated 𝑫𝑩 values throughout the duration of one experiment. 
 
Figure 30: 𝑫𝑩 values during cuff experiment on left arm of healthy subject. 𝑫𝑩 baseline values 
(green) decreased after pressure was applied to the arm (red) and increased pass baseline after the 
pressure was released (blue) before gradually lowering to baseline. 
As observed in Figure 30, prior to cuff inflation, our readings are stable and 
consistent. After cuff inflation, the blood flow is occluded, thus an immediate decrease In 
the 𝑫𝑩 values is observed which correlates with decreased blood flow. Upon cuff release, 
pressurized blood rushes into the area, significantly increasing the 𝑫𝑩 values which then 
gradually drop down to baseline values. The results from these experiments provided 
validation for the ability of the DCS system to identify changes in microcirculatory blood 
flow in a clinically relevant setting. Prior to clinical studies, an intermediate study using a 
porcine model was conducted to validate the ability of our DNIRS system to identify 
tissue injury in live perfused tissue. Details of the study are presented on the next section.  
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CHAPTER 5: ASSESSMENT OF TISSUE DAMAGE USING DNIRS IN A 
PORCINE MODEL 
No adequate animal model for the modeling of tissue injury which is both compatible 
with our current DNIRS system and representative of the complex pathology of human 
pressure ulcers was found. Existing pressure ulcer models involve the implantation of a 
foreign object (plastic or metal) beneath the skin to the animal to create artificial pressure 
ulcers [34]. The implanted objects would interfere with the scattering and absorption 
patterns of light in an unpredictable way; affecting the performance of our device and 
rendering the testing of efficacy of the device via such methods questionable. In addition, 
most models do not address deep-tissue damage that is thought to play an important role 
in the development of PUs in humans [24].  
In order to successfully complete aim 1.3 of this research project and adequately 
validate the efficacy of the DNIRS system to differentiate tissue damage at different 
depths, an in-vivo porcine burn model was utilized. A well-established protocol for 
creating tissue damage at controlled depths in porcine skin using exposure to high 
temperatures for controlled time periods was employed [207]. Comparing the depth of 
tissue damage calculated by our device against histological samples provided a 
quantitative assessment of the efficacy of the device to differentiate between healthy and 
damaged tissue at a variety of depths. The results of the study provided proof of concept 
for the assessment of the depth of tissue damage in-vivo using our technology. 
5.1 The Porcine Burn Model 
Pig skin has very close functional and structural similarities to human skin and provides 
an ideal model for testing the efficacy of our device [208]. The general cellular 
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morphology, epidermal thickness, cellular composition, immunological reactivity and 
cellular turnover of pig skin are analogous to that of human skin [209]. In addition, the pig 
model has similar healing properties (healing time and healing method) to that of human 
skin [210]. Although a cheaper alternative, rodents were not used because their skin is 
noticeably different than human skin in depth, distribution of hair follicles, and the 
presence of the panniculus carnosus muscle layer, which induces wound healing by 
contraction of the skin rather than epithelialization [208]. Guinea pigs have been used in 
multiple studies as a reliable burn model [209]. However, the pig burn wound model is 
more representative of human skin for the previously stated reasons and the size of the 
guinea pigs/rodents would decrease the number of wounds that could be inflicted per 
animal (increasing the number of animals needed for the study). The pig model provides 
sufficient space to compare multiple wounds at multiple depths of interest on the same 
animal; increasing the sample size while reducing the number of animals needed and the 
variability of our wound environment. 
5.2 Animal Study Description 
5.2.1 Surgical Procedure and Measurement Protocol 
The animal protocol was approved by Drexel University’s Institutional Animal Care and 
Use Committee (IACUC) and was conducted in accordance with the “Guide for the Care 
and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal 
Resources and published by the National Institute of Health (NIH Publication No. 86-23). 
A Yorkshire swine weighing approximately 25 kg was purchased and transported to the 
Drexel University College of Medicine laboratory animal resources facilities. The animal 
was acclimated for a period of one week, with free choice access Purina Porcine lab diet 
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5084 and fresh water. Baseline measurements of healthy intact animal skin were taken 
following the acclimation period. Anesthesia was induced using isoflurane (5%) 
delivered by mask and maintained on isoflurane (2-3%) for the duration of the 
measurement session. The animal was intubated and mechanically ventilated to control 
the rate of breathing and reduce motion artifacts during measurements. After hair 
removal, wound sites (n=8) were marked by 2.5 cm circles, 3 cm apart in the dorsal area 
of the animal using a surgical marker, 4 sites on either side of the spine. Our device used 
a semi-contact configuration in which the incident light was delivered via lenses and 
detected through an optical fiber in contact with the animal skin. Two different lasers 
(685 & 830 nm) were used to find the absorption (µa) and reduced scattering (µs’) 
coefficients of the probed tissue. The optical probe was placed in the center of each circle 
and measurements were obtained at 3 different modulation frequencies (100, 150 & 200 
MHz) at source-detector separation ranging from 4mm to 10mm.  
Six days after baseline measurements, the same sites were used during the 
creation of the burns. The pig was anesthetized with isoflurane, and received 
buprenorphine (0.1 mg/kg IM) and meloxicam (0.3 mg/kg IM) for pain relief. A total of 
eight burns of two different depths (4 burns at each depth) were induced on the back of 
the animal (4 on each flank). The superficial (n=4) and deep (n=4) burn sites were 
staggered to correct for possible variations in optical properties due to anatomical 
differences from one location to the next as shown in Figure 31 . 
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Figure 31: Staggered locations of deep (whitened) and superficial (redden) burns to account for 
possible optical variations in anatomical locations. 
 A well-established protocol for creating burns of controlled depths in porcine 
skin was followed [15, 211]. The burns were created by applying a cylindrical copper rod, 1-
inch in diameter and 15 cm in length, at a temperature of 100°C to the animal skin for a 
duration of 3 seconds (for superficial burns) and 20 seconds (for deep burns) with all 
pressure supplied by gravity. The metal rod was preheated to the desired temperature by 
immersing it in a bath of boiling water for at least one hour. In a clinical setting, 
reassessment of the burn is crucial due to the dynamic changes in the local 
microcirculation which do not develop completely until 48 hours after injury [212]. Thus, 
optical properties of each burn were measured immediately after the burn was created (0 
hours) and again 2 hours after the burn procedure in order to test the sensitivity of the 
device for detecting small local changes in microcirculation related to tissue viability 
during the early post burn period. Figure 32 shows the device set up during 
measurements. 
 
Figure 32: (Left) View of overall device set up during optical measurements including the operating 
computer which runs the device. (Right) Close up of semi-contact configuration during 
measurements. 
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5.2.2 Tissue Harvesting 
Approximately four hours after the burn procedure, the animals were euthanized and full 
thickness excisions of 2 cm by 2 cm were taken from each burn area as well as adjacent 
healthy skin. The biopsies of normal/unburned tissues were placed in formalin for later 
histopathological analysis and correlation to the optical data. Each tissue sample was then 
grossed to generate 2 tissue blocks from which one block was paraffin embedded and the 
other one kept frozen. Upon completing tissue harvesting, the animal was disposed of 
properly in accordance with laboratory animal procedures. 
5.3 Animal Study Results and Discussion 
5.3.1 Optical Results 
A difference in optical properties and hemoglobin content of deep and superficial burns 
was observed. Measurements at higher modulation frequencies, although more stable for 
phase readings, did not differ in optical properties for the same location when compared 
to lower frequencies. Consequently, measurements from all three frequencies were 
averaged within each location at each time point prior to statistical analysis. The μa and 
μs’ were compared from superficial to deep burns using two-factor ANOVA. There was a 
statistically significant difference between the μs’ of superficial and deep burns (p < 
0.05). In addition, the reduced scattering coefficient of deep burns had a statistically 
significant difference (p = 0.017) when compared to the unburned site (baseline) while 
superficial burns had no significant difference to pre-burn measurements (p = 0.52). Over 
time, μs’ stayed relatively unchanged for superficial burns while increasing for deeper 
burns. The difference in μs’ across burn depths suggests that μs’ may potentially be used 
as a stand-alone measurement to differentiate superficial from deep burns. The values of 
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μs’ for superficial and deep burns for all three time points are presented in Figure 33. 
Similar results were obtained for the 685 nm and 830 nm wavelengths. 
 
Figure 33: Mean reduced scattering coefficients from superficial (n=4) and deep (n=4) burns 
measured before (baseline), immediately after (0 hour), and 2 hours post (2 hour) burn injuries. 
Error bars represent standard error. 
Changes in the reduced scattering coefficient are related to changes in tissue 
structure and composition. Since the tissue volume probed was deeper than 1 mm, we 
expected to see little difference between superficial and baseline (healthy skin) 
measurements as shown above. On the other hand, the depth of burnt area for the deeper 
wounds overlapped with the depth of measurements from our device (2-4 mm). 
Consequently, we were able to observe a difference in the reduced scattering coefficient 
of deeper burns compared to healthy tissue.  
The μa provides information about hemoglobin content and oxygenation. A 
sudden decrease in μa was observed for deep burns compared to a gradual decrease for 
superficial burns. After two hours post burn injury, the μa values decreased 32% from 
baseline values for deep burns compared to only 17% for superficial burns. The values of 
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μa for deep and superficial burns are shown in Figure 34 for pre and post-burn injury 
measurements at a wavelength of 830 nm. Similar results were obtained for 685 nm. 
 
Figure 34: Mean absorption coefficients at 830 nm from superficial (n=4) and deep (n=4) burns 
measured before (baseline), immediately after (0 hour), and 2 hours post (2 hour) burn injuries. 
Error bars represent standard error. 
The gradual decrease of µa in superficial burns is consistent with the dynamic 
burn wound conversions following burn injury during the early 48 hour-period as 
described in the literature [213]. The decrease in μa values observed in Figure 34 may have 
been caused by a reduction in vessel density and hemoglobin concentrations which would 
consequently reduce the amount of absorption that occurs in the probed tissue. Thus, the 
temporal trends in total hemoglobin concentrations were examined. A reduction in total 
hemoglobin concentrations ([Total Hb]) from baseline values were observed for both 
superficial and deep burns as evidenced in Figure 35.  
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Figure 35: Total hemoglobin concentration for superficial (left) and deep (right) burns. 
Concentrations of hemoglobin remained relatively unchanged for superficial burns while rapidly 
decreasing for deeper burns. 
5.3.2 Histological Results 
Burn depth and viable vessel density were estimated via histological samples. 
Hematoxylin and eosin (H&E) staining was used to assess the depth of both types of 
burns. Burn depth was approximately 1 mm for all superficial wounds and 2-3 mm for 
the deeper burns. The results from H&E staining are shown in Figure 36: 
 
Figure 36: Depth of damage for superficial and deep burns with a 100x magnification of the tissue 
stained. Healthy skin is included for comparison. 
H&E stained slides were observed under a digital microscope to quantify viable 
vessel density. 42% of vessels in the dermal layer were viable for superficial burns, 
compared to only 25% for the deeper burns. The amount of viable vessels in each group 
correlated with the detected reduction in total hemoglobin concentration. Deep burns had 
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a decrease in total hemoglobin concentration of approximately 35% from baseline values 
(p < 0.05), while superficial burns only experienced a 5% decrease from baseline values 
(p = 0.37). Figure 37 shows digital slides used to count the viable vessels of superficial 
and deep burn samples.  
 
    
Figure 37: Digital microscopy slides of viable vessel density for superficial (left) and deep (right) 
burns. Yellow indicates viable vessels with hyperemia; green represents damaged vessels with no red 
blood cells and blue indicates completely necrotic vessels. 
Trichrome and reticulin staining were also performed to assess any changes in 
collagen concentration and reticular fiber degradation respectively. No differences in 
collagen concentration and/or reticular fiber composition were found between superficial 
and deep burns as observed in Figure 38. 
 
Figure 38: Trichrome (left) and reticular (right) staining results. No difference in collagen 
concentration and/or reticular fiber composition was found between superficial and deep burns. 
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5.4 Animal Study Conclusions 
Results from the in-vivo study suggest that a difference in optical properties and 
hemoglobin content could be detected when comparing deep and superficial burns to 
healthy tissue (baseline) with the developed optical system. Overall, the differences 
detected in optical properties and hemoglobin content by optical measurements correlated 
with the extent of injury observed in histological stains. 
Although statistical differences in the absorption coefficients were not observed, 
the reduced scattering coefficient showed a statistically significant difference between the 
superficial and deep burns. Differences between superficial and healthy (pre-burn) areas 
were not observed in the optical data. The probed tissue volume for pre-burn, superficial, 
and deep burns was assessed at the same penetration depth of approximately 2-3 mm as 
illustrated in Figure 39. Since the probed volume was essentially missing the superficial 
tissue, one would expect to see little difference between superficial and pre-burn 
measurements as observed in the experimental results. On the other hand, a difference 
between deep and pre-burn measurements would be expected since the penetration depth 
coincided with that of deeper burns. 
 
Figure 39: Illustration of the depth of penetration (ΔD) during measurements of healthy skin, 
superficial burns, and deep burns. Due to the majority of photos traveling a path 2-3 mm deep into 
the tissue, optical properties from healthy skin and superficial burn areas did not have any 
observable differences. 
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In addition, the burn protocol used failed to produce a deep enough burn to assess 
real deep tissue injury. The deepest burn depth achieved was only 2mm in depth. 
However, even with a small difference in depth, the system was able to quantifiably 
differentiate between the two groups of burns. A larger sample size may help detect a 
statistically significant difference in absorption coefficients along with the use of a deeper 
burn as the comparison group. Prior to aim 2, the set-up of the DNIRS system was 
changed to a fully contact configuration which could be easily used in a clinical setting. 
The evaluation of our combined system in a clinical study examining sacrococcygeal 
tissue in spinal cord injury patients with discolored skin caused by either a phase 1 
pressure ulcer or suspected deep tissue injury will be discussed in the next Chapter.  
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CHAPTER 6: ASSESSMENT OF TISSUE DAMAGE IN HIGH RISK PATIENTS 
FOR PRESSURE ULCER DEVELOPMENT 
The overall goal of the proposed study was to validate the efficacy of the combined 
Diffuse Correlation Spectroscopy (DCS) and Diffuse Near Infrared Spectroscopy 
(DNIRS) system for the detection of tissue damage underneath the skin before it is 
clinically apparent. Patients with limited mobility who are unable to off-load the weight 
of their body from pressure points over long periods of time are at a particularly high risk 
of ulcer formation. As pressure is applied and then released on sacrococcygeal skin in a 
hospital bed during optical measurements, a hemodynamic environment was created for 
validating the devices' ability to detect changes in blood flow and tissue oxygenation and 
how they relate to tissue viability. The DCS and DNIRS devices described in chapter 4 
were combined into a single probe so that tissue oxygenation and blood flow can be 
measured simultaneously within the same volume of tissue. With the combined system, 
tissue can be measured at depths of up to 1 cm beneath the surface. 
6.1 Clinical Study Design  
All procedures involving human subjects were conducted in compliance with human 
subject protection guidelines and approved by the Drexel University College of Medicine 
Institutional Review Board (IRB) and the Magee Rehabilitation Center IRB. The 
proposed study investigated changes in the microcirculation associated with the 
progression of pressure ulceration, specifically in suspected deep tissue injury. Prior to 
measurements on medical patients, validation experiments were conducted on healthy 
volunteers. The goals of these experiments were (1) to measure “normal” baseline blood 
flow and oxygenation in healthy volunteers, (2) to determine the optimal placement of the 
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probe in order to ensure consistent contact of the optical fibers with sacrococcygeal skin, 
and (3) to ensure the noninvasive probes are robust for use in the pilot study. The 
overarching hypotheses guiding this clinical study involved the notion that (a) there are 
measurable changes in microcirculatory tissue oxygenation and blood flow of 
sacrococcygeal skin and subcutaneous tissue as pressure is applied and then released; (b) 
the magnitude of these changes differs between patients who develop subcutaneous 
pressure ulcers and patients who do not develop them; and (c) changes in microcirculatory 
tissue oxygenation can be used to distinguish non-viable tissue from viable healthy tissue.  
6.1.1 Recruitment Criteria 
Patients with early signs of pressure ulceration were recruited from the Magee 
Rehabilitation Hospital, a federally designated rehabilitation center in Philadelphia. 
Eligible patients were 18 years of age or older and had intact sacrococcygeal skin with 
non-blanchable redness (i.e. either a Stage I pressure ulcer or suspected deep tissue 
injury) upon admission to the rehabilitation hospital or which developed during their 
hospital stay. Medical patients were ineligible for the study if they suffered from 
diabetes, venous or arterial disease, had a pre-existing sacrococcygeal stage II, III, or IV 
pressure ulcers, or were under contact and/or respiratory isolation. A transparent medical 
dressing (TegadermTM) was used to cover the probe and replaced for each measurement 
session. The sacrum is the most common location for pressure ulcer formation [214, 215] 
and was selected as the location for optical measurements in medical patients. 
Furthermore, mean sacral tissue thickness has been reported to be 26±13 mm, which 
compresses to 10±5 mm when exposed to 220 mmHg of pressure making it ideal for the 
penetration depth of the system [28]. 
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Prior to recruitment of medical patients, as noted above, the protocol was 
optimized to assess ease of use in healthy subjects. Healthy subjects of 18 years of age or 
older, with no history of pressure ulcers, diabetes, venous or arterial disease were 
recruited for the study. After the robustness of the device and newly designed probe had 
been tested medical patients were recruited in parallel to healthy subjects. A total of 
twenty healthy subjects and eight medical patients were enrolled from Magee Rehabilitation 
Center. 
6.1.2 Measurement Protocol 
Changes in the blood flow and tissue optical properties were recorded from healthy 
volunteers and medical patients as pressure to the sacrum was applied and then released 
by moving the subject on a hospital bed. The optical probe held the fibers in a fixed 
geometry and redirected non-ionizing laser light (785 nm) towards the skin using prisms. 
During measurements, the probe was covered with a transparent, disposable sheet of 
polyurethane (TegadermTM, 3M, Corp.), and came in contact with the patient’s skin using 
gentle pressure. The protocol started with baseline measurements on the sacral area while 
the subject was lying on their side for 1-2 minutes. Next, measurements were taken 
continuously while the subject was moved into supine position with the probe pressed 
between the sacral area of the subject and the bed to induce ischemia for approximately 
10 minutes. During the last stage of the protocol, the subject was moved from the supine 
position back to the lateral position while optical measurements were continued for 
another 2-3 minutes. The measurement protocol was repeated during three additional 
days over the course of two weeks or until the patient developed a stage II, III, or IV 
pressure ulcer. Two weeks from the last measurement session, the medical chart of each 
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medical patient was examined to determine whether a stage II, III, or IV pressure ulcer 
developed after measurements were completed. The detailed measurement protocol for 
medical patients is given below and illustrated in Figure 40: 
1. Subject was asked to remove all clothing from the waist down and don a 
hospital gown (if not already wearing a gown). Nursing assistance was provided 
if needed. 
2. The research team explained the loading and off-loading protocol. 
3. TegadermTM was placed on the device probe / mat. 
4. The patient was moved into lateral position with the assistance of a nurse. 
5. Digital Photography: Digital photographs of the intact skin area with non-
blanchable redness were taken prior to DCS/DNIRS measurements. 
6. The device probe was placed on the sacrococcygeal skin of the subject. 
7. DNIRS/DCS Sacrococcygeal Measurements: The following three 
sacrococcygeal measurements were performed sequentially: 
• Baseline measurement: With the subject in lateral position, tissue 
oxygenation and blood flow was measured on unloaded sacrococcygeal.  
• Induced Ischemia measurement: Subject was assisted into supine position 
and measurements taken on loaded sacrococcygeal skin.  
• Reperfusion measurement: Subject was assisted into lateral position and 
measurements taken on unloaded sacrococcygeal skin.  
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Figure 40: Visual representation of measurement protocol for healthy and medical patients. Subjects 
were placed in a lateral position, moved to the supine position, and finally moved back to the initial 
lateral position during measurements. An entire measurement session lasted approximately 15 
minutes. 
It was anticipated that in some patients, the non-blanchable redness would 
progress to stage II, III, IV pressure ulcers, and in other patients the redness would 
disappear. In patients who developed advanced ulcers, the microcirculatory blood flow 
and hemoglobin oxygenation data obtained prior to ulceration were compared to data 
obtained from patients whose redness disappeared. It was expected that measurable 
differences in the blood flow and oxygenation between these two groups would be 
observed. Potential risks to confidentiality were minimized by the use of anonymous study 
IDs on all electronic optical and photographic data. All medical information during the study 
was kept in a locked drawer in the clinician’s office. 
6.2 Materials and Methods  
The experimental instrumentation consisted of a combination of the DNIRS and DCS 
systems previously described on Chapter 4. The DNIRS system with two avalanche 
photodiode detectors and eight multimode source fibers delivered 160 MHz intensity-
modulated light (685 nm and 830 nm) to and from the tissue. The measured intensity of 
scattered light by the DNIRS system depends not only on the tissue properties, but also 
on the sensitivity of the photodetectors, the coupling to the detector fibers, the gain of 
each detector block, and particularly on the transmission of the optical fibers. Similarly, 
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the phase shift may be different in each light source channel because the signal delay 
depends on fiber length, coupling, and the configuration of the optical switch for each 
channel. Ideally, the amplitude and phase shift should be identical for all optical fibers; in 
practice, the transmission of light is different for each optical fiber even when using the 
same light source. Differences in sensitivity of the two detector and eight source channels 
were determined by a calibration process using a circular probe where source-detector 
distances are equal. In order to eliminate these differences in amplitude and phase shift 
across different fibers, correction coefficients were calculated as follows. 
1. Record amplitude and phase measurements from each source-detector 
combination in a sequential/consecutive manner using an equidistant circular 
probe and an optical switch for cycling laser light through the different sources. 
Check that all measured amplitudes are within the linear range of each detector. 
2. Chose a source fiber as a reference to be compared with all the other source-
detector combinations. The difference in measured amplitude and phase for each 
source-detector combination reflects the different transmission of light from the 
source fibers and the different response of each detector to the same fluence of 
scattering light. 
3. Calculate amplitude correction coefficients by creating an amplitude ratio of the 
reference source-detector separation with the rest of the combinations for each 
detector. 
4. Calculate phase correction coefficients by obtaining the difference in phase shift 
between the reference source phase with the rest of the combinations for each 
detector. 
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5. Finally, create an additional multiplier for the amplitude of the second detector 
relative to the first detector by dividing the measured amplitude (subtracting the 
measured phase) from the 1st detector by the ones measured on the 2nd detector. 
The correction coefficient data were used to correct subsequent experimental 
measurements of amplitude and phase shift by multiplying the measured amplitudes by 
the amplitude correction coefficients, and adding the phase correction coefficients to the 
measured phases. An example of the amplitudes and phase shifts obtained with an 
equidistant probe are shown in Table1, and the correction coefficients that were derived 
from these data, are shown in Table 2. 
Table 1: Amplitude (in mV) and phase data (in radians) obtained using an equidistant probe (8 
source fibers equidistant to a single detector fiber). The process was repeated for the second detector. 
 
Table 2: Amplitude and phase correction coefficients derived from the data in Table 1. 
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Corrected amplitude and phase shift data were fit to the diffusion approximation 
model and the optical absorption (µa) and reduced scattering (µs') coefficients were 
calculated using equations 3-11 as shown on the 4.1.1 section of Chapter 4 [216]. The 
absorption coefficients were used to calculate hemoglobin concentration and oxygen 
saturation of the measured tissue using equation 2 from Chapter 4 above [163]. 
Additionally, both µs' and µa were used as auxiliary parameters for diffusion coefficient 
calculations using equation 17 as explained in section 4.2.1 of this thesis.  
The system was controlled by a single laptop computer using a LabVIEW® 
software interface which alternates data collection between the DCS and DNIRS systems. 
During DCS measurements, all DNIRS system laser sources were shuttered using the 
optical switch, ensuring the light does not affect the autocorrelation function. Transistor-
transistor logic (TTL) signals from the data acquisition board to the driver of the long 
coherence laser allowed the cycling of the DCS light source ON and OFF in order to 
avoid irradiating the tissue during DNIRS measurements. At each measurement time 
point, the DCS device calculated a single blood flow index using the mean of 
autocorrelation functions gathered over a 1.5 seconds time period. Following this, the 
DNIRS device completed a single measurement (involving the scanning of 2 separate 
wavelengths through 8 source optical fibers) in ~2.5 seconds. The optical absorption, 
reduced scattering coefficients and blood flow index (BFI) at each time point were 
calculated and specific markers of disease were quantified, including the changes in 
induced ischemia and reperfusion BFI values relative to baseline BFI averages, as 
described below in section 6.4. A block diagram of the combined system is shown in 
Figure 41 and a photograph of the system is seen in Figure 42. 
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Figure 41: Block Diagram of DNIRS and DCS systems. DCS components are shaded in gray color. 
 
Figure 42: Photograph of combined DCS and DNIRS system with prism probe pad and operating 
computer. 
6.3 Optical Data Validation 
Measurements from human patients in a fast-paced clinical setting are subject to practical 
difficulties not encountered in the controlled environment of a laboratory, such as motion 
artifacts or non-uniform contact between the optical probe and the tissue. It is important 
to note that the medical patients were often paraplegic or quadriplegic, making proper 
placement of the probe and movement of the patient a bit challenging. To prevent 
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unstable measurements from being included in data analysis, all optical data were 
subjected to the following validation steps: 
1. At all measurement positions the probe was held in continuous contact with the skin 
tissue throughout the entirety of the protocol. Due to the wide range of source-
detector separations in the DNIRS system, data points where the signal amplitude was 
outside the linear range of the detectors, as described under Section 4.1.3, were 
discarded. As a result, all source-detector distances which recorded intensities less 
than 1 mV were removed from the data pool. At the start of measurements the 
maximum recorded intensity from the DNIRS system was kept below 150 mV to 
ensure the detectors would not become oversaturated with laser light. 
2. The means and standard deviations of the detected amplitudes and phase shifts were 
computed at each stage of the three stages of the protocol. Measurements were 
discarded if the percent deviation was greater than 25% over the course of each 
protocol stage. Consecutive data points within each data subset (baseline, ischemia, 
and reperfusion) were also compared to remove outliers that were found three 
standard deviations above or below the respective subset mean. This was done to 
eliminate errors caused by motion artifacts from the movement of the patient on a 
hospital bed from supine to lateral position and vice versa. A similar validation was 
done for BFI values calculated by the DCS system; however prior to this step noise in 
the raw BFI data was reduced by taking the moving 3 point average of the data 
points. 
3. Additional validation was conducted to ensure proper contact was made between each 
detector fiber and sacral tissue. The measured amplitude and phase were fitted to the 
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simplified analytical solutions of the diffusion approximation for semi-infinite 
geometry where the log(Aatt * ρ2) and the phase shift show a linear dependence on ρ, 
where ρ is the source-detector distance and Aatt is the intensity of scattered light 
registered by the detector, as described above in equation 12 on section 4.1.1. 
Measurements that did not exhibit good fitting (theoretical fit lines were visually 
separated from their corresponding experimental values and complete overlap was not 
achieved throughout the entire temporal autocorrelation function of intensity) were 
likely to have had improper tissue contact and were discarded. 
In preparation for the clinical study, the experiment detailed in Section 4.2.3 
where a sphygmomanometer was used on the left arm of a healthy subject was conducted 
to ensure hemodynamic changes could be detected by the system. Continuous 
measurements were taken on the forearm prior, during, and after applying pressure. 
Figure 43 shows the calculated concentrations of oxygenated hemoglobin and 
deoxygenated hemoglobin throughout the duration of the experiment.  
 
Figure 43: The concentration of oxygenated hemoglobin (left) steadily decreased from baseline values 
(blue) after pressure was applied to the arm (red) and increased pass baseline after pressure was 
release (green) before gradually coming back to baseline. Inversely, deoxygenated hemoglobin (right) 
concentration goes up when blood flow was occluded with the pressure cuff and comes back down 
when pressure was released. 
Oxygenated Hemoglobin Deoxygenated Hemoglobin 
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As observed above, measurements were stable and consistent prior to cuff 
inflation. After cuff inflation, blood flow was occluded, thus the amount of oxygenated 
blood gradually decreased as the surrounding tissue metabolized the available oxygen. 
Simultaneously, the amount of deoxygenated blood increased as oxygenated blood 
became deoxygenated. Upon cuff release, a large amount of oxygenated blood rushed 
into the area, increasing the amount of oxygenated hemoglobin and displacing some of 
the deoxygenated blood. The oxygen saturation was also calculated. Results correlated 
with the observed oxyhemoglobin trends. Figure 44 shows the calculated oxygen 
saturation during the experiment. 
 
Figure 44: Percent oxygen saturation during cuff experiment. 
The pressure cuff experiments showed that the optical absorption (μa) of the tissue 
changed throughout the experiment while the reduced scattering coefficient (μs’) stayed 
virtually unchanged (< 5% change). The unchanging values of μs’ during the cuff 
experiments indicate that the effects of drastically decreasing and increasing blood flow 
by inflating and deflating the cuff respectively, do not significantly affect the values of 
μs’ on the surrounding tissue. This means that changes in μs’ during our current 
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measurement protocol may not be the main contributing factor for values of BFI 
associated with increased or decreased perfusion, allowing for the use of a single fixed 
μs’ value during data analysis. 
During the clinical trial, prior to every measurement session, the performance of 
the optical system was validated by taking measurements of a silicone phantom with 
known optical properties in order to assure the device was functioning properly. Figure 
45 shows the stability and consistency of the reduced scattering coefficient obtained from 
optical phantom measurements from day to day using 830 nm laser light. These 
validation measurements helped ensure that observable changes in optical data were due 
to perfusion and tissue oxygenation changes rather than device variability. 
 
Figure 45: Stability of measured optical properties from silicon phantom over time. Percent 
deviation was less than 8% over this representative 21-day period. Measurements were taken prior 
to measuring human subjects in order to assess the device was functioning properly and consistently 
throughout the clinical study. 
The DCS system is able to calculate BFI values either by using fixed optical 
properties throughout the entire protocol or by using the averaged optical properties 
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obtained from the DNIRS system for all three stages of our experimental protocol. 
Physically, an increase in μs’ represents a higher number of scattering events in the media 
being probed. More scattering events, related to moving particles, would cause faster 
intensity fluctuations in the speckle pattern of the laser light used in our DCS system. This 
increase is then correlated to a faster blood flow in the probed area. The opposite is true 
when a decrease in μs’ occurs, manifesting itself as fewer fluctuations in intensity for an 
equal period of time and represented as slower blood flow. The clinical study results 
suggest microcirculatory blood flow changes may be sufficient to predict the early 
development of advance pressure ulcers which manifest as non-blanchable redness in 
intact skin.  
Theoretically, combining the DCS system with a method of obtaining tissue 
optical properties (such as DNIRS) would provide absolute values of BFI in the tissue 
being probed. If unchanging optical properties of the tissue are assumed during 
measurements on patients, the DCS system can only provide relative changes of blood 
flow, since absolute values require knowledge of the absorption and reduced scattering 
coefficients (μs’) of the tissue being probed. Because of this, in addition to information 
about tissue oxygenation and hemoglobin content, measuring μs’ values in real time from 
the DNIRS system is desirable; however, utilizing a combined system has the 
disadvantage of increasing the overall cost and complexity of the system as well as the 
difficulty of operation and maintenance.  
To better understand the importance of accurate measurements of µa and µs’ on 
BFI, the sensitivity of BFI to changes in µa and µs’ was tested via computer simulations. 
It was determined that doubling the absorption coefficient (µa) changes the BFI by less 
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than 10%, whereas doubling the scattering coefficient (µs’) changes the BFI by nearly 
400% [203]. To determine how the variance of µs’ values impacted the variance of BFI 
values, BFI was calculated from a set of autocorrelation data obtained from 
representative patients using constant values for µa and µs’ of 0.1 cm-1 and 10 cm-1 
respectively. These BFI values were compared to BFI values calculated using the same 
autocorrelation data with experimentally measured values of µa and µs’. The variability in 
BFI when using measured values of µa and µs’ was greater than BFI variability using 
fixed values. This was likely due to motion artifacts and improper contact of the DNIRS 
portion of the probe with the probed skin (particularly in the supine position). Most 
importantly, the general trend for changes in BFI throughout the stages of the protocol 
was similar for both analyses as observed in Figure 46.  
 
Figure 46: General trends of changes in BFI values from baseline to reperfusion for medical patients 
whose redness dissipated (patients 1-4) and those who developed advanced ulceration (patients 5-7).   
The BFI values calculated above indicated that utilizing fixed optical values 
provided similar results to those calculated using measured optical properties. However, 
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the optical properties used to create the above graph represent less than 30% of the 
optical properties collected during the clinical study. The comparison on Figure 46 was 
made using the small subset of optical data which passed the validation/exclusion criteria 
described at the beginning of this section. From the subset of validated DNIRS data, 
differences between healthy and medical patients could be observed as shown in Figure 
47. However, given the possible variations in optical properties caused by motion 
artifacts (which would lead to variations in perfusion calculations) and irregular tissue 
geometry, it is the author’s belief that the sacral region is not an optimal location to 
employ the proper use of the DNIRS system for pressure ulcer assessment and 
classification.  
 
Figure 47: Tissue oxygen saturation throughout the three stages of the protocol for a healthy subject 
(left) and a medical patient who developed and open ulcer (right). A large drop in tissue oxygenation 
is experienced by the medical patient when moved to the supine position while only a small change in 
percent oxygen saturation is observed by the healthy subject. Motion artifacts and poor tissue-probe 
contact prevented further comparison of tissue hemodynamics between different patient groups. 
Due to the low percentage of usable DNIRS data, which excluded the majority of 
patients, the optical properties for each individual patient were not able to be calculated. 
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Instead, representative values of μa and μs’ from usable DNIRS data were created for 
each of the patient groups by averaging the usable optical properties within each group. 
Thus, the ‘measured’ optical properties used to calculate the BFI for both medical patient 
groups in Figure 46 only reflect average values from an incomplete data pool and should 
not be mistaken with optical properties obtained from individual measurement sessions. 
Given the lack of sufficient DNIRS data, fixed values of 0.1 cm-1 and 10 cm-1 for µa and  µs′  were used for calculation of BFI throughout the data analysis. 
Due to the use of modulated light in the DNIRS system rather than the continuous 
wave used in DCS, the optical properties measured with the DNIRS system were more 
susceptible to motion artifacts. As previously stated, other factors such as improper probe 
contact with the skin due to the shape and curvature of the sacral region, as well as 
optical complications created by a tissue-probe gap significantly reduced the amount of 
usable DNIRS data for the calculation of optical properties. In DNIRS systems that use 
intensity modulated light, the amplitude attenuation and phase delay of the sinusoidal 
wave are typically attributed to the absorption and scattering events occurring within the 
tissue. After baseline measurements have been obtained, additional changes in 
attenuation and phase delay are attributed to hemodynamic events within the tissue. 
However, when there is non-uniform probe contact, the gap between the skin and the 
optical fibers causes additional signal delay and intensity attenuation due to loss of light 
to the surroundings and the longer distance needed to be traveled by the photons. 
Diffusion approximation is highly dependent on the source-detector distances and 
requires a pencil-point laser source; both of which are affected in a DNIRS system by a 
gap between skin and optical fibers. In addition, physiological effects and changes due to 
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motion artifacts would both be represented in the detected signal, which would 
potentially lead to data misinterpretation. The DCS system, on the other hand, uses a 
continuous wave signal which can only provide amplitude information and does not have 
(and thus is not affected by) phase changes. In addition, a long coherence length laser is 
used in DCS systems which can stay focused for up to 10 meters and thus maintain 
pencil-point geometry across significant tissue-fiber gaps. 
6.4 Clinical Study Results 
Out of the eight patients measured, the sacrococcygeal redness of five patients dissipated by 
the end of the study while three patients developed an advanced-stage pressure ulcer (stage 
II, III, or IV). All patients had similar intact skin with non-blanchable redness during the 
first measurement session. A total of twenty healthy subjects were measured. After data 
validation, average BFI values for each of the three stages of the protocol were calculated 
for individual measurement sessions and compared across different patient groups. The 
difference in the measured temporal autocorrelation function of intensity (G2) was observed 
between patients who developed open ulcers (POs) and patients whose redness disappeared 
and did not develop an open ulcer (PNOs). The autocorrelation curve of PNOs looked 
similar to that of healthy subjects as observed in Figure 48.  
  
Healthy Subject Patient – Redness Disappeared Patient – Developed Ulcer 
(A) (B) (C) 
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Figure 48 (continued): Typical experimental temporal autocorrelation function of intensity for (A) 
healthy subjects, (B) PNOs, and (C) POs. The baseline ( ), ischemia ( ), and reperfusion ( ) 
sections of the protocol are represented for each group along with theoretical fits of the data ( ). 
The above figure shows how the correlation functions of POs shifted to the left 
during the baseline and reperfusion stages of the protocol, indicating a faster blood flow 
compared to healthy subjects and PNOs. The correlation functions of POs during the 
ischemic stage had a larger shift to the right compared to PNOs and healthy subjects. 
Moreover, the experimental data during ischemia for POs had poor agreement with the 
theoretical fit of the utilized diffusion equations. This may potentially be indicative of 
compromised or abnormal vessel structure causing irregular or shunted flow (anastomosis 
between two blood vessels which bypasses the capillary bed) under pressure. The calculated 
BFI values throughout the entirety of the protocol are shown in Figure 49 for representative 
healthy subjects and representatives from each group of patients. Due to the magnitude of 
the differences between BFI values across different groups, a logarithmic scale was used to 
show relative changes.  
 
Figure 49: Blood flow index comparison between representative healthy and medical patients. 
Measurement of healthy subjects and healed patients look similar, while patients who opened within 
two weeks of the last measurement session have BFI values an order of magnitude larger. 
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The baseline BFI values of POs were up to ten times larger than that of healthy 
subjects (two sample t(9) = -3.42, p = 0.007) or PNOs (two sample t(9) = -3.37, p = 
0.008). The distribution of baseline BFI values across all the measurement sessions for 
each of the three groups of subjects could be easily discerned in a histogram as shown in 
Figure 50.  
 
Figure 50: Distribution of baseline BFI values of healthy subjects and medical patients. All of the 
measured PO subjects had higher baseline BFI values than any of the healthy or healed patients.  
Figure 50 shows baseline blood flow index values alone can be used to differentiate 
between POs (M = 2.05x10-8, SD = 1.6x10-8) and PNOs (M = 2.65x10-9, SD = 1.11x10-9). 
Interestingly, faster blood flow indexes were observed in patients who developed ulcers 
compared to those whose redness dissipated (two sample t(9) = -3.37, p = 0.008). The 
baseline measurements from all POs yielded BFI values greater than ~0.5x10-8cm2/sec, 
while none of the baseline BFI values for healthy or healed subjects surpassed this 
threshold.  
When looking at shifts in blood flow index values from one stage of the protocol 
to the next, a difference between groups was also observed. The ischemia shift was 
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calculated by subtracting the average baseline BFI value from the average ischemia BFI 
value, while the reperfusion shift was calculated by subtracting the average baseline BFI 
from the average reperfusion BFI value for the measurement sessions from each subject. 
The largest shift in blood flow index was observed from baseline to induced ischemia 
(while under the loading position). When moved from baseline to the loading position, 
POs experienced a decrease in BFI values approximately one order of magnitude greater 
than that of healthy subjects (two sample t(9) = 3.46, p = 0.007) and PNOs (two sample 
t(9) = 3.56, p = 0.006) as observed in Figure 51.  
 
Figure 51: Average difference in BFI values between baseline and ischemia measurements for 
healthy subjects and medical patients. The drop in BFI values was higher for medical patients who 
developed open ulcers than healed patients or healthy subjects. 
These data suggest that differences in BFI from baseline values can be used to 
predict which medical patients will have skin breakdown within a two-week period 
versus those who will heal. The drop in BFI values from baseline when moving the 
patients to the supine position (induced ischemia) can be better assessed by representing 
the magnitude and direction of the change in BFI for each of the individual measurement 
sessions for every patient as shown in Figure 52. 
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Figure 52: Change in BFI between the baseline and the induced ischemia stages of the protocol. PO 
subjects (MP2, MP6 & MP7) have a larger decrease in blood flow index than PNO patients. The 
different red bars indicate individual measurement session while the larger rectangles indicate the 
different patients. All patients had similar non-blanchable redness during the first measurement 
session. 
The figure above shows the statistically significant drop in BFI values 
experienced by patients who later developed an open ulcer in comparison to those 
patients who healed (two sample t(9) = 3.56, p = 0.006). Not all patients had four visits 
due to the sacral redness either dissipating or developing into an open ulcer prior to the 
fourth measurement session. It is worth mentioning that the optical data collected from 
MP4 and the first session of MP5 were subject to significant motion artifacts by the 
patient and difficulties in probe placement. Research subject MP4 was lost to follow up 
due to an emergency transfer prior to the second measurement session and was excluded 
from statistical analysis.  
Individually, the three different stages of the measurement protocol provided 
information about the risk of advanced pressure ulcer formation. The reperfusion 
response, as the patient was moved from a load bearing position back to a lateral position, 
was of particular interest when compared to baseline values since it showed a temporal 
106 
 
   
trend which allowed further distinction between POs and PNOs. POs consistently 
exhibited a downward trend over time in their BFI shifts from baseline to reperfusion as 
shown in Figure 53. This systematic decrease may further indicate a progression in the 
structural deterioration of the microvasculature from day to day until eventual ulceration. 
It is important to note that only two measurement sessions were performed on MP7 due 
to ulceration prior to the third session; the downwards trend however, is still apparent. 
 
Figure 53: Change in BFI between baseline and reperfusion stages of the measurement protocol. 
Patients who developed an open ulcer (right from vertical line) exhibit a consistent drop in the 
magnitude of reperfusion blood flow index from day to day, while no specific pattern was observed in 
patients whose redness disappeared (left from vertical line). 
The change in the downward trend of the reperfusion shift over time was 
calculated from day to day for all medical patients and the values of the slopes from each 
patient’s trendline were recorded as observed in Figure 54 and Table 3.  
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Figure 54: Shift in reperfusion blood flow index from baseline values as patients are moved from a 
load bearing position back to a lateral position. Patients who developed an open ulcer exhibit a 
consistent drop in the magnitude of reperfusion blood flow index from day to day, while no specific 
pattern is observed in patients whose redness disappeared 
Table 3: Slope values for each of the reperfusion shift trendlines of medical patients who developed 
an open ulcer (red) and those who did not (blue). Slope values organized from negative to positive. 
  Developed Skin Breakage  Redness Dissipated  
Patient MP7 MP2 MP6 MP5 MP8 MP4 MP3 MP1 
Reperfusion Shift Slope 
(1x10-9 cm2/sec/day)  
-20 -4 -2 -0.6 -0.1 0 0.002 0.8 
As observed above, medical patients who developed open ulcers have a 
downwards trend in the shift of reperfusion BFI from baseline values over time with a 
negative slope which is at least three times larger than that of healed patients. We 
hypothesize that the negative slopes may be related to an increasing decay in structural 
integrity of the microvasculature over time as the deep tissue injury progresses to the 
surface and destroys viable vessels. For medical patients whose redness dissipated, the 
108 
 
   
reperfusion shift slopes were either positive or slightly negative; potentially indicating 
improving or unchanging microvasculature health.  
In addition, data from this study suggest that using the described optical system 
can more reliably predict a patient's risk of pressure ulceration than the widely used 
Braden scale. Table 4 provides a comparison between indications from our optical data 
against the risk level determined by Braden scores from each individual patient recorded 
upon admission.  
Table 4: Comparison between results from our optical data versus Braden scores. The indications 
from the optical data were a more reliable predictor of pressure ulceration than the risk levels 
assigned by the respective Braden scores. 
 
 
 
 
6.5 Discussion and Conclusions 
Based on the experimental results, some physiological hypotheses were made. The baseline 
blood flow indices of PNOs had similar values and distribution to that of healthy subjects. In 
healthy tissue, faster blood flow may be interpreted as a higher influx of nutrients and 
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oxygen to the probed area; however, in patients with compromised circulation, increased 
blood flow does not necessarily reflect the tissue nutritional status. Previous studies have 
demonstrated an increase in blood flow in diabetic patients during hypoxia and capillary 
ischemia of several organs [217-220]. Similarly, patients with venous insufficiency often have 
skin with increased blood flow while tissue nutrition is severely impaired [221]. It is possible 
that POs were experiencing shunting of capillary networks due to damaged 
microvasculature which would result in faster flow through surrounding viable vessels, 
and thus, elevated BFI values during measurements. 
The observed decrease in BFI in POs from baseline to ischemia may be due to 
compromised capillary networks and the malfunction of microvascular regulation. A 
larger decrease in blood flow from baseline values may be indicative of damaged or 
impaired microcirculation which is not able to sustain proper blood flow under the load 
of the patient’s body. The increased metabolic demand along with localized ischemia 
may eventually lead to cell apoptosis and necrosis of the surrounding tissue. In addition, 
if shunting of the blood through nearby viable capillary networks is responsible for the 
observed elevated baseline BFI values in patients who developed ulcers, the additional 
strain to the surrounding vessels by blood devoid of nutrients and saturated with wastes 
could potentially accelerate their deterioration and eventual breakdown. If this hypothesis 
is valid, in addition to baseline BFI values, medical patients at high risk of developing an 
open ulcer may be identified by monitoring drops in BFI values while patients are 
routinely moved in a hospital bed as part of their standard of care.  
Results from this study indicated that the described optical system may be a 
clinically-relevant screening tool to assess the risk of advanced ulceration in patients with 
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intact skin and non-blanchable redness. Throughout each of the stages of the protocol, 
BFI data could be used to distinguish between POs and PNOs within two weeks of 
recruitment. The change in BFI between the baseline and ischemia stages as well as the 
decreasing values of reperfusion BFI over time were also different for the two groups of 
medical patients. It is expected that with a larger patient cohort, the statistical power of 
the study could be increased in support of the observed results. 
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CHAPTER 7: CONCLUSION AND FUTURE WORK 
The non-invasive quantitative assessment of sub-surface tissue damage to detect pressure 
ulceration before it is clinically apparent has the potential to shift current clinical practice 
in evaluating pressure ulcer risk and diagnosing deep tissue injury. The DNIRS and DCS 
systems used have the ability to simultaneously interrogate the structural integrity of 
tissue, hemoglobin concentration, tissue oxygenation, and microcirculatory blood flow. 
The two approaches can either work independently or together to provide static and 
dynamic information related to changes in tissue hemodynamic status or 
microvasculature blood flow over time at depths ranging from several millimeters up to 1 
centimeter. Other systems such as the SFDI may be comparable modalities but are still in 
their infancy and comprehensive human studies are needed to assess their clinical 
potential and widespread acceptance.  
7.1 Summary and Overall Conclusion 
The purpose of this research was to determine whether DNIRS and DCS 
modalities could be used to detect changes in tissue oxygenation and microcirculation on 
intact skin as they relate to underlying tissue damage, whether the measured changes 
could be used to differentiate superficial from deep tissue injury, and whether 
DNIRS/DCS data could be used to predict the early onset of pressure ulceration. A study 
of burn depth in a porcine model and a clinical study on high risk patients for pressure 
ulceration were conducted in order to meet these goals. 
To summarize the results of the animal study, a pig model was used for in-vivo 
validation of the system given its close functional and structural similarities to human 
skin. The optical properties and hemoglobin concentrations of 4 deep and 4 superficial 
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burns were assessed in the dorsal area of a Yorkshire swine and compared for pre- and 
post-burn measurements. Differences in optical properties and hemoglobin content 
correlated with the extent of observed tissue injury from histological samples and were 
used to differentiate between superficial and deep burns. A statistically significant 
difference between the optical properties of superficial and deep burns (p < 0.05) was 
observed. Over time, μs’ stayed relatively unchanged for superficial burns while 
increasing for deeper burns. These changes correlated with the larger change in tissue 
composition undergone by deeper burns. The values of μa decreased up to 32% for deep 
burns compared to 17% for superficial burns which may be directly related to the 
observed reduction in vessel density and hemoglobin concentrations.  
Burn depth and viable vessel density were estimated via histological samples with 
42% of vessels in the dermal layer remaining viable for superficial burns, compared to 
25% for deep burns. H&E stained slides showed the depth of superficial burns to be 
approximately 1 mm while deeper burns were approximately 2-3 mm in depth. The 
temporal trends in total hemoglobin concentrations were also different between deep and 
superficial burns. Decreased vessel density correlated with the observed reduction in total 
hemoglobin concentration for both wound types. Deep burns had a decrease in total 
hemoglobin concentration of approximately 35% from baseline values (p < 0.05), while 
no significant difference from baseline was observed for superficial burns (p = 0.37). The 
differences detected in optical properties and hemoglobin content by optical 
measurements correlated with the extent of injury observed in histological stains. Overall, 
the study served as a proof of concept for the use of our system in the assessment of in-
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vivo tissue viability under intact skin as well as the characterization of the degree and 
severity of different tissue injuries.  
To summarize the clinical study examining sacrococcygeal tissue for pressure 
ulcer assessment, 20 healthy volunteers and eight medical patients were measured using 
the DCS/DNIRS system for a maximum of 4 sessions. Out of the eight patients measured, 
the sacrococcygeal redness of five patients dissipated by the end of the study while three 
patients developed an advanced-stage pressure ulcer (stage II, III, or IV). Baseline blood 
flow index values alone could be used to differentiate between patients who opened (POs) 
and those who healed (PNOs). The baseline BFI values of POs were approximately 7 to 
10 times larger (faster) than that of their healthy (p = 0.007) and healed (p = 0.008) 
counterparts. In contrast, the baseline blood flow indices of PNOs had similar values and 
distribution to that of healthy subjects. This may be due to the health of the tissue 
progressively improving over time for PNOs and reaching similar functionality to that of 
healthy subjects. Similarly to the burn study, it is also possible that the superficial damage 
was not detected because the device was probing deeper into the tissue.  
In addition, POs experienced a decrease in BFI that was approximately one order 
of magnitude greater than that of healthy subjects (p = 0.007) and PNOs (p = 0.006) 
when moved from baseline to a load bearing position. When looking at the average shifts 
in BFI values from baseline to reperfusion, a systematic decrease in the reperfusion 
response of POs was observed for consecutive measurement sessions while PNOs 
exhibited no particular temporal trends. This may be indicative of the progression of 
vascular destruction which eventually resulted in ulceration. Overall, the results from this 
pilot study suggest that DCS technology has the potential to predict risk of ulceration in 
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patients with intact skin and non-blanchable redness. Data from each of the three stages 
of the protocol show potential for differentiation of superficial and deep tissue damage. 
The large difference in blood flow changes observed between patient groups may 
possibly be used in the future as an indicator of suspected deep tissue damage or the 
likelihood of pressure ulcer formation. 
Our human data suggest that changes in BFI throughout each of the individual 
stages of the proposed protocol can predict the early onset of pressure ulceration with 
nearly 100% specificity and sensitivity when at least 4 measurements are made over a 
period of 2 weeks or more. The author acknowledges that a larger number of patients is 
needed to properly evaluate the observed results and increase the statistical power of the 
study. Additional evaluation is needed to better determine the minimum time period 
needed to accurately predict ulceration with the DCS/DNIRS system and to assess if a 
shorter measurement protocol may provide similar results. However, the results of the 
study indicate that the DCS/DNIRS system may be able to supplement and enhance the 
sensitivity and specificity of early pressure ulcer detection in comparison with currently 
used risk assessment tools such as the Braden Scale and potentially help with objective 
classification of Stage 1 and SDTI.  
7.2 Future Work 
Future research should be conducted to assess the ability of the system for early 
detection of reversible tissue damage prior to visual manifestation. Previous studies have 
reported that the effects of ischemic injury on mechanical function, membrane potential, 
metabolism, and ultrastructure can be reversible if the duration of ischemia is short [29]. 
However, if ischemia persists for longer periods of time, the affected cells become 
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irreversibly injured; making the timely non-invasive inspection of high risk areas upon 
admission a potential driver for reducing hospital cost and time of stay while optimizing 
treatment options. Irreversible ischemic injury refers to ischemic injury of sufficient 
severity and duration that the involved cells will continue to degenerate and become 
necrotic despite re-oxygenation by reperfusion of arterial blood [29]. The use of our 
system to non-invasively identify irreversibility would be beneficial, particularly because 
the appearance of necrosis through current methods is delayed for about 12 hours 
following the injury from which cells cannot recover [29].  
As stated above, future work should also include the assessment of pressure ulcers 
in a larger study to further validate the findings and increase the statistical power of the 
study. The pilot human study described here was limited to 8 medical patients and 
focused on the creation of a proper measurement protocol that could differentiate stage 1 
pressure ulcers from SDTI by looking at existing redness in the sacrococcygeal area. 
Exploring the use of DCS/DNIRS in assessing the likelihood of pressure ulcer 
development in other high risk areas such as the heel, where motion artifacts can be more 
easily controlled and a proper contact could be maintained can also be beneficial.  
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APPENDIX A: ABBREVIATIONS, ACRONYMS AND SYMBOLS 
 
 
 
Abbreviations and Acronyms 
3D = three dimensional 
Aatt = amplitude attenuation of the incident modulated light 
ABS = acrylonitrile butadiene styrene 
AC = alternating current 
AD = analog devices 
ADT = active dynamic thermography 
Air = amplitude response of the instrument 
APD = avalanche photodiode 
BFI = blood flow index 
c = speed of light in the medium 
CCD = charge-coupled device 
ci = concentration of the i-th chromophore 
CLSM = confocal laser scanning microscopy 
cm = centimeter 
CT = computerized tomography 
CW = continuous wave 
D = diffusion coefficient 
DAQ = data acquisition 
dB = decibels 
DB = diffusion coefficient 
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DC = direct current 
DCS = diffuse correlation spectroscopy 
DNIRS = diffuse near infrared spectroscopy 
DRS = diffuse reflectance spectroscopy 
Eb = emissive power 
FCD = functional capillary density 
FD = frequency domain 
FDA = Federal Drug Administration 
g = angular dependence of scattering 
G1 = electrical field temporal autocorrelation function 
G2 = measured temporal autocorrelation function of intensity 
gs(τ) = temporal autocorrelation function of scattered light intensity 
GUI = Graphical User Interface 
H&E = hematoxylin and eosin 
H2O = water 
HeNe = Helium-Neon 
hrs = hours 
HSI = hyperspectral imaging 
I/Q demodulators = in-phase and quadrature demodulators 
(I) = output cosine DC signal from I/Q demodulators 
I = registered light intensity 
IACUC = Institutional Animal Care and Use Committee 
IRB = Institutional Review Board 
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k0 = photon wave number 
kB = Boltzmann constant 
kg = kilograms 
kimag = imaginary part of the diffusion wavenumber 
kreal = real part of the diffusion wavenumber 
l’ = transport length 
LCT = liquid crystal thermography 
LDF = laser Doppler Flux 
LDI = laser Doppler imaging 
LDPI = laser Doppler perfusion imaging 
LDPM = laser Doppler perfusion monitoring 
LED = light-emitting diode 
LO = local oscillator 
LSCI = laser speckle contrast imaging 
LSI = laser speckle imaging 
m = meter 
mg = milligram 
MHz = megahertz 
min = minute 
mL = milliliters 
mm = millimeter 
mmHg = millimeters of mercury 
MRI = magnetic resonance imaging 
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mV = millivolts 
n = number of different chromophores in the medium 
n0 = index of refraction  
Nair = refraction index of air 
NIH = National Institute of Health 
NIM = Nuclear Instrumentation Module 
NIR = near-infrared 
nm = nanometer 
NPUAP = National Pressure Ulcer Advisory Panel 
ns = nanoseconds 
Ntissue = refraction index of tissue 
OCT = optical coherence tomography 
OPSI = orthogonal polarization spectral imaging 
PNO = patients whose redness disappeared and did not develop an open ulcer 
PO = patients who developed open ulcers 
PS-OCT = polarization sensitive optical coherence tomography 
PU = pressure ulcer 
(Q) = output sine DC signal from the I/Q demodulators 
r = diameter of the sphere 
R2 = coefficient of determination 
RBC = red blood cell 
Reff = effective reflection coefficient 
RF = radio frequency 
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RMCM = reflectance-mode confocal microscopy 
RTV = room temperature vulcanizing 
s = seconds 
SDTI = suspected deep tissue injury 
SFDI = spatial frequency domain imaging 
SPCM = single photon counting module 
StO2 = oxygen saturation 
T = temperature 
t = time 
TiO2 = titanium dioxide 
TRS = time domain 
TTL = transistor-transistor logic 
U.S. = United States 
USB = universal serial bus 
z = vertical distance from the source to the tissue 
Zb = distance from the turbid medium surface to an extrapolated boundary condition 
outside the turbid medium 
µm = micrometer 
 
Symbols 
[Hb] = deoxyhemoglobin concentration 
[HbO2] = oxyhemoglobin concentration 
°C = degrees Celsius 
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α = product often used as a blood flow index with unit [ ], because light scattering in 
tissue mostly occurs at non-moving tissue structures 
β = coherent factor which depends on the number of speckles detected and the coherence 
length and stability of the laser 
εi = extinction coefficient of the i-th chromophore 
ελHb = molar extinction coefficient of deoxyhemoglobin 
ελHbO2 = molar extinction coefficient of oxyhemoglobin 
η = viscosity of water 
θ = angle of scattering 
λ = wavelength 
µ’s = reduced scattering coefficient 
µa,H2O = absorption coefficient of pure water 
µa = optical absorption coefficient 
π = pi 
ρ = distance between source and detector fibers 
σ = Stefan-Boltzmann constant 
τ = delay time of autocorrelator 
Φ = phase shift of the incident modulated light 
ω = modulation frequency 
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